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Abstract 
Overexpression of a RHAMM isoform (RHAMMΔ163) transforms fibroblasts but the 
mechanisms underlying this oncogenic function are not well understood. RHAMMΔ163 binds 
to the mitotic spindle and centrosomes via a C-terminal leucine zipper; these interactions are 
predicted to regulate genomic stability and cell polarity and proposed to account for the 
oncogenic function of RHAMMΔ163.  We hypothesized that RHAMM leucine zipper 
maintains mitotic spindle integrity and impacts directional cell migration through its 
interactions with microtubule and centrosome structures. The consequences of a mutated 
leucine zipper on cell division, cell motility, and tumorigenesis were assessed. Although 
mutant RHAMMΔ163 promoted polycentrosomy, it did not alter cell cycle progression and did 
not strongly affect proliferation or tumorigenesis. However, loss of the leucine zipper 
function blocked directional movement of fibroblasts without affecting rate of motility.  
These results suggest that the RHAMM leucine zipper selectively regulates directed 
migration, which is a centrosome function that contributes to tumorigenesis. 
Keywords 
RHAMM, leucine zipper, mitosis, microtubules, cell division, centrosomes, cell migration  
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Chapter 1  
1 Introduction 
 
Constant cell turnover is required for the maintenance of cellular homeostasis and 
requires a delicate balance between mitogenic growth signals that regulate cell 
proliferation and anti-proliferative signals that help mediate cell death (1, 2). Proto-
oncogenes and tumor suppressors, in part, maintain this regulation. Whereas proto-
oncogenes, like Ras and c-Src, are essential for proper cell growth, proliferation, 
migration and differentiation, tumor suppressors, such as the retinoblastoma protein, Rb, 
and the transcription factor, p53, repress the cell cycle and promote cellular apoptosis to 
prevent aberrant cell growth (3). Mutations in these regulatory pathways that disrupt 
homeostasis, not surprisingly, result in the progression of diseases such as cancer. Cells 
ignore regulatory cues that normally inhibit cell cycle progression thereby promoting 
tumor growth (3). Strict regulation of the mechanisms that govern cell division must 
therefore be tightly regulated.  
 
1.1 Regulation of mitotic cell division  
 
Two main steps characterize cell division: DNA replication during interphase and then 
the subsequent separation of replicated chromosomes into two daughter cells during 
mitosis (4). Interphase is comprised up of three phases: G1, S, and G2, whereby a cell 
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prepares for DNA replication (G1), replicates its DNA (S), and then prepares the cell to 
undergo mitosis (G2) (4). DNA replication during S phase is also linked with centrosome 
replication to ensure that both DNA and centrosomes are only replicated once during 
each cycle of cell division (5). Centrosome replication involves the duplication of a pair 
of centrioles and their subsequent separation to spindle poles during prophase of mitosis. 
Centrioles are linked together through an amorphous mass of coiled coil proteins called 
the pericentriolar material (PCM) (5). These proteins are recruited to the spindle poles via 
motor proteins to help carry out centrosome function (6-8). Centrosomes make up the 
microtubule-organizing center (MTOC) in mammalian cells and function as a major site 
for microtubule nucleation (7). They also influence a number of cellular functions such as 
cell polarity and migration, establishment of a bipolar mitotic spindle, and thus proper 
cell division (9). 
Following DNA and centrosome replication, a cell is ready to undergo mitosis. Mitosis is 
a very brief, yet highly complex and tightly regulated stage of the cell cycle. Mitotic cell 
division, which is described as the division of the parent cell into two genetically 
identical daughter cells, occurs in eukaryotic tissues and is critical for development and in 
maintaining tissue homeostasis (10). The mitotic phase is characterized by five 
consecutive stages including: prophase, metaphase, anaphase, telophase, and cytokinesis. 
During this process, centrosomes migrate to opposite poles of the cell and signaling 
events promote microtubule nucleation from several sources, predominately the MTOC, 
but also from chromosomes (11). The microtubule network then organizes itself to form a 
bipolar mitotic spindle. Microtubules emanating from centrosomes in the MTOC attach 
to protein structures, referred to as kinetochores, on the chromosomes, which then aligns 
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the chromosomes midway between the two poles and aids in the separation of the sister 
chromatids to each spindle pole of the developing daughter cell (12, 13).  
The mitotic spindle machinery is comprised of microtubules, centrosomes, chromosomes, 
molecular motors, microtubule-associated proteins, and numerous spindle assembly 
protein factors that ensure spatial-temporal spindle formation (13). 
Amongst other factors, Ran GTPase plays a pivotal role in mitotic spindle formation by 
creating a Ran-GTP gradient around chromosomes (14, 15). Once a gradient has been 
established, proteins that promote microtubule nucleation and stability are activated. One 
target of Ran-GTP is TPX2 (targeting protein for Xklp2), a spindle assembly protein 
factor that upon activation is released from inhibition by importin-α and initiates 
microtubule nucleation and activation of downstream targets like Aurora kinase A 
(AURKA) (16). AURKA is a mitotic serine/threonine kinase that is predominantly 
activated by TPX2 and whose role is to phosphorylate key proteins to facilitate in the 
organization of a bipolar spindle (17). Not surprisingly, inhibition of Ran activity results 
in aberrant mitotic spindles and chromosomal abnormalities (18). Furthermore, molecular 
motors like dynein, walk along microtubules and carry spindle-associated proteins to 
their minus ends to ensure proper formation, function and integrity of the mitotic spindle 
(19). One example of a spindle-associated protein is the receptor for hyaluronan-mediated 
motility, RHAMM. RHAMM associates with dynein at the spindle poles and it functions 
to ensure the formation of a bipolar spindle (19). The mechanism by which RHAMM 
regulates mitotic spindle assembly is not fully understood, however, its genetic deletion 
results in mitotic defects characterized by multipolar mitotic spindles (20).  
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Cells employ additional checkpoint mechanisms during spindle assembly to monitor and 
regulate proper spindle formation. Assembly of the mitotic spindle is controlled by two 
linked checkpoints: the kinetochore attachment checkpoint and the spindle assembly 
checkpoint (SAC). The kinetochore attachment checkpoint ensures that all chromosomes 
are stably attached by their kinetochores to mitotic spindle microtubules from either 
spindle pole (21).  The cell then relays the status of the kinetochore-microtubule 
attachment to the SAC. If all chromosomes are attached properly to the spindle poles, 
chromosome segregation commences. If, however, chromosomes are not attached 
properly, it signals the intact SAC to halt the cell cycle and delay anaphase until all 
chromosome kinetochores are properly attached to the microtubule spindles (22). Failure 
to attach can lead to chromosomal missegregation and thus this regulatory mechanism is 
essential in maintaining genomic stability within a cell. When proteins that regulate the 
SAC become mutated, the fidelity of chromosome segregation becomes compromised as 
the SAC becomes defective and cells ignore the checkpoint and continue cell division 
(22, 23). Segregation defects can result in a gain or loss of part or whole chromosomes 
leading to chromosomal instability, which is a major driving force in cancer 
progression(10). Changes to chromosome number can result in a state of aneuploidy and 
changes to chromosome structure can lead to loss or translocation of critical genomic 
DNA, both contributing to genomic instability, which then has the potential to drive these 
premalignant cells cancerous (22).  
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1.2 Cancer Development 
 
Cancer development is a complex, multi-step process that arises as a result of multiple 
genetic alterations that drive the transformation of normal cells to malignant cancer cells. 
During cancer initiation, oncogenes become hyperactivated and acquire gain-of-function 
mutations, whereas mutations in tumor suppressors accumulate and cause their loss-of-
function (24, 25). These mutations give rise to numerous types of human cancers all 
governed by disruption of a subset of key cellular processes. Hanahan and Weinberg (26) 
identified several key hallmarks of cancer that promote a cell’s progression from a 
normal state to a malignant transformed phenotype. Based on this, a cancer cell must 
initially acquire the ability to autonomously grow, resist anti-growth cues, and ignore 
signals for programmed cell death (26). 
Cells normally require mitogenic factors that bind to their respective receptors and 
stimulate a signaling cascade to promote cell proliferation. Conversely, transforming cells 
do not rely on exogenous growth signals to propagate, but rather have the ability to 
synthesize their own mitogenic factors to sustain their proliferation(26). Furthermore, 
these cells overexpress cell surface receptors that become overly responsive to growth 
factors and this results in a deregulation of downstream signaling pathways, such as that 
of the mitogenic Ras-Raf-MAP kinase cascade(26). Cancer cells may acquire mutations 
that induce constitutive expression of the Ras oncogene and enables them to bypass 
signaling through their upstream receptors (27).  
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Tumor cell proliferation is often linked with resistance to anti-growth signals that is 
otherwise associated with normal cells. Normal cells receive cues from their environment 
to halt the cell cycle and enter a state of quiescence in G0 or enter into a post-mitotic state 
in order to maintain homeostasis (26). This regulation is achieved through tumor 
suppressors such as Rb and p53 (26, 28, 29). Rb helps to regulate cell cycle progression 
and apoptosis by controlling the function of E2F transcription factors and thus the 
progression from G1 to S phase of the cell cycle (30). p53 is essential during the DNA 
damage response in cells and arrests the cell cycle or initiates apoptosis if the damage 
cannot be repaired (28).  When mutated or inactivated, these tumor suppressors lose their 
function and cells are not able to respond to anti-growth signals, thus promoting 
tumorigenesis.  
Not only do cancer cells resist anti-growth cues, but also become insensitive to signals 
promoting programmed cell death, which in turn disrupt cell homeostasis. Signals that 
typically activate the apoptotic machinery include defects in cell division, either DNA 
replication or during mitosis as well as cellular stresses arising from DNA damage, 
accumulation of ROS species, or hypoxia (26). Conversely, cancer cells acquire 
mechanisms to evade apoptosis by up-regulation of anti-apoptotic factors, such as Bcl-2, 
or by inactivation of the tumor suppressor p53 (26, 31). This attribute allows cancer cells 
to thrive and become resistant to cancer therapies (26).  
While these hallmarks are all critical for the primary transformation of normal cells into 
malignant phenotypes, arguably the deadliest characteristic of cancer cells, which 
accounts for more than half of cancer related deaths (32), is their ability to metastasize to 
distant tissues and form secondary lesions. In order to metastasize, cancer cells acquire 
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increased migration and invasion abilities. Therefore, the events regulating cell migration 
and invasion must be finely tuned to prevent triggering a cell’s metastatic potential.  
 
1.3 Cell Migration 
 
Cell migration is essential during many cellular processes including embryogenesis, 
tissue regeneration, wound healing, and immune surveillance (33, 34). Migratory events 
are generally tightly regulated and when they are perturbed can play a causative role in 
numerous diseases such as chronic inflammation, autoimmune diseases, and tumor 
progression and metastasis (35-37). 
Several biochemical pathways are involved in the initiation of cell migration and are 
predominantly regulated by the Rho family GTPases, including Rac1, Cdc42, and RhoA 
(34, 36). The Rho family of GTPases is a subset of the Ras superfamily and these 
proteins play a vital role in cell migration by regulating the actin network, microtubule 
dynamics, and several signal transduction pathways (33, 35, 38, 39). They function as 
molecular switches cycling between an inactive GDP-bound form, where they reside in 
the cytosol, and upon activation to their GTP-form they translocate to specific 
membranes or the actin cytoskeleton where they interact with target proteins and generate 
a downstream signal (33, 34). 
During cell migration, specific Rho family GTPases, Cdc42 and Rac1, interact with their 
targets and first polarize the cell and orient it towards the migration front end (34). 
Activated Cdc42 and Rac1 stimulate actin polymerization to form finger-like projections 
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or protrusions, filopodia and lamellipodia, respectively, at the leading edge which are 
used to establish stable adhesions to the substratum (33-35). To initiate cell migration, 
RhoA regulates the assembly of actin and myosin bundles, which facilitate the 
contraction of the cell body and the rear end of a cell to detach rear adhesions and 
translocate toward the leading edge (40). Migratory events require adhesion sites at the 
leading and rear end of the cell to alternatively assemble and disassemble via actin 
reorganization in a spatiotemporal manner to propel a migratory cell forward (33-35). 
The role of microtubules during cell motility is not well established, but a dynamic 
microtubule network is required (40). Microtubules are present in both the leading and 
trailing edges, but are more dynamic at their tails. Inhibition of microtubule dynamics 
blocks cell migration due to an inability of cells to retract their trailing edges (40). Loss 
of the microtubule network via treatment of cells with high concentrations of nocodazole 
inhibits directional cell migration and as a result cells move more randomly (40).  
Directed cell migration depends on the polarization of microtubules and the reorientation 
of the MTOC towards the direction of migration. During migration, microtubules 
function as tracks for motor proteins to transport cellular cargo towards the leading edge 
and for regulating cell polarity and shape (41). Microtubule minus ends emanate from the 
MTOC, where they are nucleated from and are dynamically unstable at their plus ends. 
Stabilization of the plus ends during cell migration enables the MTOC to reorient itself 
towards the direction of migration at the leading edge (33, 41).  The major component of 
the MTOC is the centrosome and centrosomes are known to play an integral role in cell 
polarization as its damage/loss disrupts directed motility (42). Regulation of these 
pathways are dependent on Rho GTPases, particularly Cdc42, which acts through its 
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effectors to control the position of the nucleus relative to the MTOC and also plays a role 
in microtubule orientation (34, 38). 
De-regulation of migratory pathways is seen in a number of metastatic cancers. Cell 
migration of cancer cells is augmented via communication between the cell and its local 
microenvironment, which constitutes the extracellular matrix (ECM) and other cells such 
as stromal cells, fibroblasts, and immune cells  (39, 41, 42).  These cells begin to 
overexpress growth factors and chemokines, which bind to cancer cell receptors and elicit 
pro-migratory pathways (43, 44).  An enhanced migratory ability allows cancer cells to 
invade into the ECM and local microenvironment and travel on ECM fibers to blood 
vessels. Carcinoma cells then intravasate into the blood stream where they travel via the 
vasculature to distant sites, extravasate and form secondary tumors (43). 
 
1.4 Extracellular Matrix 
 
The ECM is an intricate network of macromolecules that provides structural and 
functional support to the surrounding cells within a tissue (38, 45). Cells interact with the 
ECM through the integrin family of transmembrane receptors as well as other cell surface 
receptors, such as RHAMM (46-48). The attachment of these cell receptors to the ECM 
elicit a variety of biochemical signal transduction pathways that in turn regulate 
numerous cellular functions including, cell growth, migration, differentiation, and 
maintaining tissue homeostasis (47). Abnormalities in ECM proteins are seen in a wide 
variety of human diseases (49).  In particular, aberrations in ECM components give 
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cancer cells the ability to promote tumor proliferation, migration and invasion. As well, 
deregulation of the ECM components impacts the surrounding cells in the local 
microenvironment, including stromal cells, immune cells, and fibroblasts, and together 
help promote disease progression (48, 50, 51). Therefore, understanding the role of ECM 
proteins and how they affect signaling pathways can provide insight into how cancer is 
initiated.  
Two main classes of macromolecules make up the ECM: fibrous proteins and 
glycosaminoglycans (GAG). Fibrous proteins present in the ECM include collagen, 
fibronectin, and elastin, just to name a few, and they help to maintain the ECM’s 
structure by providing tensile strength, protecting against stretches in the tissue, and in 
mediating cell adhesion to the ECM (45). Conversely, GAGs are large, extremely 
hydrophilic polysaccharides and their ability to form hydrogels serves an essential role in 
resisting compressive forces (45). GAGs have a wide variety of other functions that are 
molecule and tissue-specific. 
  
1.4.1 Hyaluronan 
 
One GAG of interest, hyaluronic acid/hyaluronan (HA), is found widely distributed 
throughout the ECM of all vertebrates. Its negative charge at neutral pH and hydrophilic 
nature attracts water molecules within the ECM, giving it an essential lubrication and 
hydration function(52). HA is a high molecular weight GAG with an average molecular 
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mass of 4x106 Da and it is composed of alternating disaccharide units of D-glucuronic 
acid and D-N-acetylglucosamine (53, 54).  
Hyaluronan is synthesized by hyaluronan synthases (HASes), of which there are three 
conserved genes—HAS1, HAS2, HAS3—each with a unique spatial and temporal 
expression pattern (52). During embryonic development, HAS2 synthesizes the majority 
of hyaluronan present (52) and its expression is also unregulated during tumor 
progression in a number of cancers, including breast cancer, mesothelioma, and colon 
cancer (52, 55-57).  
Conversely, hyaluronan is degraded by a number of hyaluronidases (HYALs), with the 
two most prominent HYALs being HYAL1 and HYAL2. Aberrant expression of either 
has been seen in invasive ductal carcinoma (52, 58, 59).   
Hyaluronan also functions as a signaling molecule in a number of cellular processes 
including cell migration, proliferation, and during wound healing (52). In particular, HA 
synthesis is consistently and transiently increased immediately after tissue injury and in 
sites of rapid tissue turnover, including embryogenesis, inflammation, and neoplasia (52). 
The vast functions of HA are dependent on its molecular weight (48)—degradation of 
HA gives rise to bioactive molecules that function differently than full-length forms. For 
example, full-length hyaluronan is antiangiogenic and immunosuppressive, whereas 
hyaluronan fragments promote angiogenesis and inflammation (48, 60-62). 
HA mediates its effects through interactions with a class of proteins referred to as the 
hyaladherins. This class of hyaluronan-binding proteins differs in their cellular 
distribution, either within subcellular compartments or on the cell surface, and the 
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sequences by which they interact with HA and thus the effects they exert are hyaladherin-
specific (63). One hyaladherin of interest is RHAMM, which interacts with HA both 
intracellularly and at the cell surface and their interactions regulate a number of cellular 
functions including cell proliferation and cell migration (64, 65).  
 
1.5 RHAMM structure and function 
 
RHAMM was first isolated and purified from subconfluent migrating cardiac fibroblasts 
as a cell surface hyaluronan binding protein (66, 67). It is largely an acidic coiled-coil 
protein with a basic amino-terminal globular head (68, 69). RHAMM binds to hyaluronan 
via two carboxyl terminal coiled domains that are rich in basic amino acids and are 
commonly referred to as B(X)7B motifs (70, 71). This region partially overlaps with one 
of two microtubule-binding sites of RHAMM—an N-terminal sequence for associating 
with interphase microtubules and a C-terminal binding region for interacting with mitotic 
spindle microtubules, the latter of which overlaps with the HA binding site (20, 69). 
RHAMM also contains a highly conserved D-docking site common to many ERK 
binding substrates (Figure 1.1B) (20).  
RHAMM protein contains a number of leucine zipper domains and along with its coiled 
coil structure predicts that it can form homodimers or heterodimers with its binding 
partners (71, 72). One particular leucine zipper domain of interest is located within the C-
terminal microtubule-binding region and this sequence presumably functions in and 
regulates RHAMM and mitotic spindle interactions/integrity (Figure 1.1C) (19, 20, 73). 
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RHAMM protein is found in many species and is predominantly studied in humans, 
mice, and Xenopus laevis, where the protein sequences are most homologous at their N- 
and C-termini (74). The RHAMM gene is comprised of 18 exons and is located on 
chromosome 5 in humans; its mRNA transcript encodes an 84-kDa protein (Figure 1.1 A) 
(75). In mice, the RHAMM gene is localized to chromosome 11 and its mRNA transcript 
encodes a 95-kDa protein. Furthermore, the RHAMM gene in Xenopus encodes a 150-
kDa protein and it is 45% and 65% identical to human and mouse RHAMM, respectively 
(74).  
RHAMM expression is tightly regulated and is absent or present at low levels in most 
homeostatic human tissues. Protein and mRNA levels of RHAMM, however, are 
transiently and strongly up-regulated during tissue repair (64, 76). Surprisingly, genetic 
deletion of RHAMM in mice displays no visible defects during embryonic development, 
albeit with slow healing of skin wounds, owing to its essential role during wound repair 
(64).  
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Figure 1.1 Schematic Representation of RHAMM  
A) The RHAMM gene is comprised of 18 exons. Exons 4 and 16 contain tubulin-binding 
sequences, for binding to interphase and mitotic spindle microtubules, respectively. B) 
Full-length RHAMM encodes a 794 amino acid protein sequence. RHAMMFL contains 
two tubulin-binding sites, at the N-terminus and C-terminus. The C-terminal end of 
RHAMM contains HA and ERK binding sites that overlap with the leucine zipper motif. 
RHAMMΔ163 is an oncogenic isoform and only contains the C-terminal tubulin binding 
sequence. C) Amino acid sequence of a C-terminal RHAMM fragment containing the 
leucine zipper motif (highlighted in pink) with overlapping HA and ERK binding sites 
715
HQNLKQKIKHVVKLKDENSQLKSEVSKLRSQ
745
 
D domain for ERK binding  HA binding  
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Furthermore, elevated RHAMM expression is associated with several pathologies, 
including arthritis, diabetes, and several human cancers (77-81).  
RHAMM is present in many cell types, including:  fibroblasts, smooth muscle cells, 
immune cells, and endothelial cells, just to name a few (20, 82-84).  
It is a multifunctional protein with extracellular and intracellular functions that affects 
cell motility/invasion and mitotic spindle integrity/genomic stability, respectively. 
RHAMM is part of a heterogeneous group of cell surface proteins that lack an N-terminal 
signal peptide and is therefore not exported through the classic Golgi/ER route (85). This 
class of proteins is nonetheless released to the extracellular compartment via poorly 
characterized unconventional export mechanisms and in response to specific stimuli (85). 
For example, during cell transformation in multiple myeloma and in highly invasive 
breast cancer cell lines, the putative oncogene RHAMM is unconventionally exported to 
the cell surface, where it contributes to tumor formation (85, 86). Other stimuli that 
induce RHAMM export include cell stress, during cell transformation or wounding (87). 
Extracellular RHAMM is not integrated into the plasma membrane by membrane 
spanning sequence or by GPI tail. At the cell surface, it functions as a co-receptor, 
binding hyaluronan and a number of tyrosine and non-tyrosine kinase receptors, 
including PDGFR, RON, CD44, and TGFβR (48, 76, 88-90). 
RHAMM binding to CD44 and HA promotes cell migration through activation of the 
ERK1,2 MAP kinase pathway (64). RHAMM also interacts with and mediates activation 
of Src and focal adhesion kinase (FAK) and these interactions are essential for focal 
adhesion turnover during cell motility (65).  Furthermore, extracellular RHAMM 
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regulates cell cycle progression; blocking cell surface RHAMM results in a slower 
progression of cells through G2/M, a stage in the cell cycle where RHAMM mRNA is 
up-regulated (91).  
In addition to its localization on the cell surface, RHAMM is also present in several 
subcellular compartments, where it plays a prominent role in cell proliferation events. 
RHAMM localizes to the cell nucleus, on interphase microtubules, centrosomes, 
podosomes, and on mitotic spindle microtubules (20, 69, 72, 85). Furthermore, 
intracellular RHAMM interacts with MEK1/ERK1,2 complexes and targets them to 
microtubules, where they control the stability of interphase and mitotic spindle 
microtubules (20), and to the cell nucleus (20, 76), where they play a role in regulating 
mitotic spindle integrity, cell cycle progression, cell proliferation, and likely centrosome 
function (19, 20, 81). Deregulation of these functions not only result in defected mitotic 
spindle assembly, but also disrupt centrosome structure (19, 81, 85). RHAMM-regulated 
ERK activity is required for maintaining a bipolar mitotic spindle and defects due to 
RHAMM loss can be rescued by mutant active MEK1 (20). The complete mechanisms 
by which intracellular RHAMM carries out these functions are still being characterized.   
The complex subcompartmentalization of RHAMM is not well understood, but is likely 
attributed to specific targeting of isoforms within the cell. Several isoforms of RHAMM 
exist in cell lines, some of which are generated via alternative mRNA splicing and others 
are through alternative start codons resulting in N-terminal truncated isoforms (72, 92). 
Full-length RHAMM most often localizes to microtubules, whereas targeting of 
RHAMM to the nucleus requires either N-terminal truncations or alternative splicing (69, 
93). The N-terminal truncated forms of RHAMM appear typically after cells are plated in 
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culture as well as following tissue injury (94). One isoform, termed RHAMMΔ163, is an 
N-terminal truncation of the full-length protein and represents the oncogenic form of 
RHAMM found in many human cancers (95). In experimental models, overexpression of 
RHAMMΔ163 transforms 10T1/2 and 3T3 mesenchymal cell lines, which form metastatic 
tumors in NOD/SCID xenograft mouse models (95). The mechanisms by which 
RHAMM mediates MEF transformation, however, have not been fully elucidated. 
Aberrant RHAMM regulation of mitotic spindle integrity has been predicted to contribute 
to tumor progression by promoting genomic instability, but neither an effect on genomic 
stability or if this is relevant to progression has been directly demonstrated (73, 78). Thus 
an understanding of how RHAMM is involved in the regulation of microtubule and 
centrosome structures/function can help us better understand the oncogenic roles of 
RHAMMΔ163. 
 
1.6 The role of RHAMM in mitosis 
 
1.6.1 The role of RHAMM in microtubule and mitotic spindle 
regulation  
 
The microtubule network is composed of polymers of α- and β-tubulin heterodimers that 
make up one constituent of the structurally important cytoskeleton. A dynamic 
microtubule network with rapid turnover is necessary for cellular events such as 
formation of the mitotic spindle during mitosis. Microtubule stability is regulated in part 
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by a group of microtubule-associated proteins (MAPs), including RHAMM, that bind to 
tubulin and either directly or indirectly contribute to its polymerization and stability by 
decreasing disassembly rate (10, 41).  
Many proteins make up the microtubule-associated proteome (MTAP) and RHAMM is 
one known component (96). Its functions during mitosis are dependent on its interactions 
with and regulation of microtubules. Full length RHAMM consists of two conserved 
microtubule-binding sequences, one located in exon 4 and the other in exon 16 (Figure 
1.1A), for binding to interphase and mitotic spindle microtubules, respectively, and these 
interactions are seen in numerous cell backgrounds (20, 69, 81).  
The N-terminal microtubule binding sequence of RHAMM located in exon 4 is essential 
for binding to interphase microtubules and deletion of this region results in a loss of 
RHAMM localization from interphase microtubules and rather a diffuse distribution 
throughout the cytoplasm, as well as in the cell nucleus (19, 69). 
Furthermore, RHAMM is localized to microtubules throughout the mitotic phases of the 
cell cycle. During prophase, in both adherent, (HeLa cells), and suspension cell lines, 
(RPMI 8226 and Raji cells) RHAMM is found distributed at the center of microtubule 
asters emanating from the centrosphere (81). 
In prometaphase and metaphase, intracellular RHAMM localizes to mitotic spindle poles 
and along the length of microtubules through a carboxyl terminal region (19). 
Additionally, throughout anaphase and telophase, RHAMM is localized at the midbody 
and microtubule spindles at the midzone, respectively, where it functions during 
cytokinesis (19). Genetic deletion of RHAMM in fibroblasts results in aberrant 
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chromosome alignment/segregation and inappropriate cell division during mitosis, giving 
rise to multinucleated cells(20). Consistent with its role during cytokinesis, RHAMM has 
been shown to interact with supervillin—a gelsolin family member of proteins that 
functions in mysoin II mediated contractility during the early stages of cytokinesis (97-
99).   
Although RHAMM functions throughout the stages of mitosis, it has largely been studied 
for its role in organizing and maintaining mitotic spindle integrity. During cell division, 
the formation of a bipolar mitotic spindle ensures fidelity of chromosome segregation and 
maintains genomic stability (20).  Forced high expression or genetic deletion of RHAMM 
results in multi-pole mitotic spindles (19, 20, 73, 74), the former of which has been 
linked to genomic instability in multiple myeloma(81). Consistent with these data, siRNA 
knockdown of RHAMM in neointimal smooth muscle cells (SMCs) and HeLa cells 
resulted in multipolar spindles and disorganized spindles, further confirming RHAMM’s 
role in spindle assembly (84, 100). siRNA knockdown of RHAMM in HeLa cells also 
resulted in a delay in spindle assembly and a delay in the time required to complete 
mitosis, suggesting a role for RHAMM in microtubule nucleation (100). These defects 
can collectively be rescued by re-expression of RHAMM confirming the aberrations to be 
a particular result of the loss of RHAMM (19, 20, 73, 74, 100). Levels of RHAMM must 
thus be tightly regulated as an abundance or loss results in aberrant mitosis. 
Although the mechanism by which RHAMM regulates mitotic spindle integrity is not 
well established, previous work has highlighted an important role for the highly 
conserved leucine zipper located in exon 16 (19, 20, 73) in mediating RHAMM/mitotic 
spindle interactions (Figure 1.1C). Previous mutational analysis of the leucine zipper 
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motif demonstrated an essential role for it in maintaining spindle pole organization and 
recruitment of key spindle protein factors (73, 100). Tubulin binding assays also 
confirmed that RHAMM binds to tubulin heterodimers via its C-terminal domain and this 
interaction can be abolished by a synthetic peptide containing the leucine zipper (20). 
Furthermore, in Xenopus, binding of RHAMM to tubulin is essential for Ran-driven, 
chromatin-induced (noncentrosomal) spindle assembly (73, 74) and depletion of 
RHAMM results in defects in microtubule assembly (74). The latter two studies thus 
suggest that tubulin and mitotic spindle binding regions of RHAMM overlap, though 
direct analysis of this has not been previously published.  
The C-terminal leucine zipper motif of RHAMM partially overlaps with the hyaluronan 
and ERK1 binding sites (Figure 1.1C). It is therefore not surprising that RHAMM’s role 
in mitotic spindle integrity is in part attributed to RHAMM’s interactions with HA and 
MEK1/ERK1, 2 complexes. 
 
1.6.1.1 RHAMM and HA interactions in mitosis 
 
HA binds to intracellular RHAMM and has been shown to play a role in mitotic functions 
(101). During mitosis, HA synthesis is increased and is present in abundance (102), 
where it is found to associate with microtubules in the perinuclear area as well as more 
peripherally in the cytoplasm of human arterial smooth muscle cells(101). RHAMM also 
closely associates with microtubules and endogenous HA-positive vesicular structures; 
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these interactions are confirmed following uptake of fluorescein-labeled HA and excess 
unlabeled HA can competitively abolish the binding of HA to RHAMM (101).  
HA is also found to intimately colocalize with RHAMM in and around mitotic spindle 
microtubules of SMCs, both endogenously and following uptake of fluorescein-HA, 
suggesting a role for both in the organization of astral and spindle microtubules. In later 
stages of mitosis, HA staining is present in abundance throughout telophase and HA is 
localized to the microtubules of the midbody during cytokinesis (101). 
In support of RHAMM/HA interactions during mitosis, both RHAMM mRNA 
expression and expression of hylauronan synthases, in particular HAS2 is elevated at the 
G2/M boundary during cell cycle progression (67). Elevated HA synthesis during G2/M 
is necessary for cell rounding as a result of cytoskeletal reorganization (101). 
Furthermore, when HAS and RHAMM expression are inhibited, prostate cancer cell lines 
arrest at mitosis (103). Given that both HA and RHAMM decorate the mitotic spindle 
and that RHAMM and HAS mRNA are elevated at the G2/M boundary supports the 
hypothesis that intracellular RHAMM/HA interactions play an integral, yet unclear, role 
in a cell’s progression through mitosis. Studies hypothesize that these interactions are 
essential for RHAMM’s role in regulating microtubule stability and spacing within a cell 
(48, 101). 
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1.6.1.2 RHAMM-dependent ERK regulation during mitosis 
 
ERK decorates interphase and mitotic spindle microtubules in both non-transformed and 
transformed cells (41, 104, 105) and has been shown to have an extensive effect on 
microtubule stability by regulating the ability of these proteins to control tubulin 
polymerization (41). 
 H-ras transformed cells, however, have higher levels of active ERK bound to interphase 
microtubules and these microtubules are less stable—indicative of constant turnover—in 
comparison to non-transformed fibroblasts. The effect of ERK regulation on these 
processes is mediated by the upstream kinases Ras-Raf-MEK (41). Inhibition of ERK-
activated signaling results in increased microtubule stability, which has been shown to 
result in multi-pole mitotic spindles (20, 41). 
RHAMM promotes interphase microtubule instability indirectly through MEK1/ERK1,2 
activity (20). Overexpression of RHAMM has been shown to constitutively activate ERK 
and expression of a dominant negative mutant form of RHAMM blocks activation of 
ERK by mutant active Ras, thus providing a role of RHAMM in ERK regulation (88). 
Intracellular RHAMM directly binds with ERK1 through a highly conserved D-docking 
site, which partially overlaps with the C-terminal leucine zipper motif (20). This binding 
site is common to many ERK binding substrates and contains both hydrophobic and 
positively charged basic residues (106). Conversely, intracellular RHAMM indirectly 
complexes to ERK2 and MEK1, as well as ERK1,2 substrates (20). Mutations in the D-
docking site of RHAMM results in a decreased binding of ERK1 in vitro and in cultured 
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cells (20). Furthermore, expressing RHAMM mutated in the D-docking site in 10T1/2 H-
ras transformed fibroblasts resulted in decreased total cellular levels of phosphorylated 
ERK1,2 (p-ERK1,2) as well as reduced detectable p-ERK1,2 from tubulin (20). In terms 
of microtubule dynamics, expression of this mutant RHAMM form promoted 
microtubule stability (20), as evidenced by an increase in the levels of acetylated tubulin 
(20). Additionally, RHAMM regulation of microtubules through MAPKs appears to be 
important in maintaining mitotic spindle formation/integrity as mitotic spindle defects 
seen in RHAMM-/- fibroblasts are not only rescued by re-expression of RHAMM, but 
also to a similar extent by mutant active MEK1 (20). This proposes a model in which 
RHAMM functions as a scaffold protein that binds ERK1 and ERK2/MEK1 complex and 
recruits them to microtubules, via RHAMM’s interactions with tubulin, to phosphorylate 
and activate other microtubule associated proteins, which then regulate microtubule 
dynamics/stability (Figure 1.2) (20, 107). With respect to the mitotic spindle, RHAMM 
controls targeting of ERK to microtubule-associated substrates and hence an absence of 
RHAMM would result in compromising spindle integrity, while overexpression of 
RHAMM could sequester ERK1, 2 from its key target substrates and result in aberrant 
localization/activation (107). 
 
24 
 
 
 
Figure 1.2 RHAMM/ERK interactions in microtubule regulation  
RHAMM functions as a scaffold protein, binding ERK1 directly and MEK1 indirectly, 
recruiting them to microtubules, via RHAMM’s interactions with tubulin, which then 
regulates microtubule dynamics/stability  
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1.6.2 RHAMM and spindle assembly binding partners 
 
Apart from microtubules, RHAMM binds to many other structures in the context of cell 
division/mitosis, which in particular assist in the regulation of proper spindle assembly.  
One critical organelle of interest is the centrosome. Centrosomes make up the 
microtubule-organizing center and are the major sites of microtubule assembly. They are 
comprised of two centrioles surrounded by an amorphous pericentriolar material (9). The 
PMC is made up of numerous coiled coil proteins that are directed to centrosomes via 
motor proteins and assist in microtubule nucleation (7). Given RHAMM’s role in 
microtubule regulation, it is not surprising that RHAMM localizes to centrosomes and 
this interaction helps to maintain both centrosome and spindle integrity during mitosis 
(19). RHAMM binds to centrosomes via its conserved C-terminal leucine zipper (19) and 
this association is seen in meiotic Xenopus extracts (74) and in mammalian cell lines 
(19). Deletion constructs of RHAMM fusion proteins lacking the leucine zipper inhibit 
the targeting of RHAMM to centrosomes (19). However, the leucine zipper alone is not 
sufficient for targeting to centrosomes as GFP-tagged C-terminal RHAMM fragments of 
100 amino acids containing the leucine zipper did not associate with centrosomes, but did 
with spindle poles (19).  
Furthermore, unregulated RHAMM expression leads to centrosome defects. Elevated 
RHAMM expression in multiple myeloma plasma cells resulted in structural, but not 
numerical, centrosomal abnormalities (81). Similarly, overexpression of RHAMM five-
fold in RPMI 8226 cells in culture results in excess PCM volume (81). Knockdown of 
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RHAMM in SMCs results in premature centrosome replication and the presence of 
fragmented and detached centrosomes (84). Not surprisingly, expression of mutant 
RHAMM in neointimal SMCs also resulted in less RHAMM being concentrated around 
centrosomes, suggesting a critical role in maintaining division fidelity at least in 
neointimal SMCs (84). Structural centrosome defects are typically seen in human cancers 
as a result of aberrant mitosis that consequently contributes to genomic instability (81).  
During mitosis, the division of the centrosome and its subsequent polar separation helps 
assemble the critical bipolar mitotic spindle. Mutating the carboxyl terminal centrosomal 
binding domain of RHAMM resulted in an increase in the number of spindle pole defects 
(84). Thus RHAMM’s localization to centrosomes provides a putative mechanism by 
which RHAMM regulates spindle assembly during mitosis and accordingly helps 
maintain genomic stability (79).  
Like many other proteins found at centrosomes, a subset of intracellular RHAMM is 
targeted to centrosomes via a complex with the molecular motor protein, dynein. In 
general, the dynein/dynactin motor complex is responsible for transporting cellular cargo 
to microtubule minus ends (19). RHAMM antibodies bind to dynein during interphase 
and a slightly higher fraction of RHAMM binds to dynein in mitotic Xenopus extracts 
(19). Co-localization studies also confirm the interaction between endogenous RHAMM 
with dynein in mammalian mitotic HeLa cells (19) and neointimal SMCs, particularly at 
the spindle poles and co-immunoprecipitation studies reveal that they are part of a 
complex (84). Whether this interaction with dynein is direct or indirect remains unknown, 
but RHAMM’s association with dynein at the spindle poles is essential in maintaining 
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mitotic spindle organization and also helps orient the mitotic spindle during metaphase 
(19, 84, 93, 100). 
Consistent with RHAMM’s role in maintaining spindle integrity, the carboxyl terminal 
leucine zipper of RHAMM shares 72 percent structural homology with that of the 
Kinesin-like protein 2 (Klp2) family (19). Klp2 proteins are plus-end associated kinesin-
like proteins whose leucine zipper domain is responsible for localizing to centrosomes via 
an indirect interaction with the dynein/dynactin motor complex(108). Xklp2, the Xenopus 
laevis Klp2 member, is crucial for the polar separation of centrosomes and in maintaining 
spindle bipolarity (19, 108) and functions via its interactions with targeting protein for 
Xklp2, TPX2 (108). TPX2 is a spindle assembly protein factor that assists in microtubule 
nucleation and assembly by activating AURKA, which recruits a number of key proteins 
required for mitotic spindle formation (74, 81, 84, 100, 109). The structural similarities 
between RHAMM and the Klp2 family of proteins would suggest that RHAMM 
functions in a similar manner to maintain spindle assembly and integrity.  Not 
surprisingly, TPX2 is one binding partner of RHAMM. These interactions are cell cycle 
dependent and the majority of RHAMM, at least 40-60%, associates with TPX2 during 
mitosis in human cells (81, 100, 110). There is no evidence in the literature to suggest 
that these proteins interact with each other at other times during the cell cycle. 
RHAMM’s interaction with TPX2 is essential for targeting TPX2 to the spindle poles and 
activation of AURKA during spindle formation (100). Immunodepletion of RHAMM in 
Xenopus meiotic cell extracts or siRNA knockdown of RHAMM in mitotic HeLa cells 
both results in the loss of TPX2 at the spindle poles (74, 100). RHAMM binds to TPX2 
via its conserved carboxy terminal leucine zipper region and this interaction is observed 
28 
 
in many cell types, including both Xenopus and human cells (19, 74). Mutation of the 
three leucines in the leucine zipper sequence to arginines abolishes TPX2 binding to 
RHAMM (100). Furthermore, an alteration in this sequence results in aberrant spindle 
formation and also disrupted localization of TPX2 in Xenopus laevis extracts and thus 
impacted AURKA phosphorylation/activation (19, 74). Interestingly, RHAMM’s 
interaction with TPX2 in human cementifying fibroma cells only occurs in the presence 
of HA (109). Note that HA production is highest during G2/M when RHAMM and TPX2 
interact, suggesting critical roles for these interactions in mitotic functions. 
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Figure 1.3: Schematic representation of RHAMM function at the mitotic spindle 
During mitotic spindle assembly, a (1) Ran-GTP gradient is established around 
chromosomes and allows for the release of TPX2 from inhibitory importins (2). TPX2 is 
free to interact with and activate AURKA (3;top), which assists in spindle pole assembly 
(4). TPX2 can also form a complex with RHAMM and dynein/dynactin (3;bottom), 
which travel along microtubules to recruit TPX2 and RHAMM to the spindle poles and 
centrosomes where they both play a role in regulating mitotic spindle integrity (4) 
(Adapted from Maxwell et al 2008 (85)) 
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1.6.3 RHAMM and cell cycle progression 
 
Consistent with RHAMM’s role during mitosis, RHAMM expression in mammalian cells 
is tightly regulated during the cell cycle, both in vitro and in vivo (79). 
Quantitative real-time PCR analysis of cultured HeLa cells synchronized at the G1/S 
phase and released from the block at various times after showed that the level of human 
RHAMM transcripts was predominantly activated at G2/M (79). This induction of 
RHAMM expression at the G2/M phase of the cell cycle coincides with the expression of 
a hallmark G2/M regulatory protein, cyclin B (79). Briefly, cyclin B expression is cell 
cycle regulated, its expression peaks during mitosis, and it is necessary for cells to 
progress through mitosis by forming a complex with the regulatory cyclin dependent 
kinase 1 (Cdk1) (4). 
RHAMM expression is also elevated at G2/M in vivo in the liver of BALB/c mice that 
were subjected to a 70% partial hepatectomy (79). Generally, the liver is a highly 
differentiated organ and is not a suitable for examining cell division except in the case 
where a hepatectomy was subjected where the regeneration of a liver exhibits normal cell 
cycle regulated gene expression. BALB/c mice showed elevated RHAMM expression 
after 48 hours during liver regeneration and this coincided with cyclin B expression at the 
G2/M phase (79).  
In line with these findings, Sohr et al (111) demonstrated that expression of both 
RHAMM mRNA and proteins are cell cycle regulated in human foreskin fibroblasts 
(HFF).  Whereas RHAMM mRNA and protein follow the same expression patterns in the 
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early stages of the cell cycle, mRNA expression peaks at G2/M, however, protein levels 
peak and begin to decrease during S phase of the cell cycle (111).  
Consistent with RHAMM’s role in G2/M regulation, ectopic overexpression of RHAMM 
in human 293T cells results in the accumulation of a population of cells in G2/M as 
demonstrated by FACs analysis (79). This suggests that overexpression of RHAMM 
affects cell cycle G2/M progression by arresting cells during mitosis. Similarly, 
overexpression of GFP-RHAMM in RPMI 8226 and HeLa cells results in a metaphase 
block during mitosis and a significant decrease in the number of mitotic cells (19, 81). 
Conversely, the knockdown of RHAMM in HCF cells results in a decrease in the 
percentage of cells at G2/M, as detected by flow cytometry (109). These results suggest 
that a tight regulation of RHAMM expression levels is essential for normal cell cycle 
progression.  
Not surprisingly, RHAMM mRNA and protein levels are indirectly downregulated by the 
tumor suppressor, p53 (48). p53 is a transcription factor that controls the expression 
patterns of many genes involved in cell-cycle regulation and apoptosis. Furthermore, the 
levels of many cell cycle regulators are controlled by degradation through ubiquitin E3 
ligases (112). The anaphase-promoting complex (APC) is one ubiquitin ligase that helps 
regulate the turnover of several spindle assembly factors, including RHAMM (113). This 
regulatory mechanism appears to be important in keeping RHAMM levels in check for 
binding to other spindle assembly factors, like TPX2, and promoting proper spindle 
assembly (107, 113). RHAMM levels are also presumably regulated by ubiqutination 
through a complex with another ubiquitin E3 ligase, BRCA1/BARD1 and this interaction 
helps to keep RHAMM levels in check to maintain a bipolar mitotic spindle (73). 
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The precise reason why and when cells need RHAMM for the progression of the cell 
cycle are not yet clear, however, RHAMM functions in this process are likely dependent 
on its interaction with, and regulation of, microtubules and centrosomes and thus its role 
in maintaining mitotic spindle and centrosome integrity.  
It is surprising, however, given RHAMM’s functions in these processes, that RHAMM-/- 
mice are not embryonic lethal and there are no obvious defects in these viable mice (76). 
This suggests that there are redundant mechanisms that help compensate for RHAMM 
loss and perhaps RHAMM is not compensated for only during specific pathologies such 
as wound repair and cancer progression. 
 
1.7 RHAMM and cell proliferation 
 
Given RHAMM’s interactions with cytoskeletal elements and proteins that are involved 
in regulating mitosis, it is not surprising that RHAMM functions during cell proliferation. 
This role, however, is often non-essential and largely cell type specific.  
RHAMM promotes cell growth in several cell backgrounds via phosphorylation and 
activation of ERK1/2 kinases (114). RHAMM loss in J82 bladder cancer cells resulted in 
reduced cell proliferation and an increase in the percentage of cells in G1 of the cell cycle 
as a result of their anti-proliferative effects; this was not due to an increase in cell death 
as no induction of apoptosis was observed after RHAMM knockdown (115). 
Furthermore, knockdown of RHAMM by siRNA in immortalized human cementifying 
fibroma cells from the jawbone resulted in a decrease in cell proliferation and an 
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inhibition of ERK1,2 phosphorylation (109). Consistent with these results, RHAMM 
overexpression in MC3T3-E1 osteoblast cell line promotes cell proliferation and induces 
ERK1,2 phosphorylation directly. Inhibiting activation of ERK1, 2 by using an inhibitor, 
PD98059, resulted in a decrease in cell proliferation of MC3T3-E1 RHAMM 
overexpressing cells (114). Similarly, blocking RHAMM function with an anti-RHAMM 
antibody abolished cell growth of Kv562 human leukemic cells (116). The effects of 
proliferation on these cells were mediated through RHAMM and were dependent on the 
presence of HA and activation of the PI3K pathway (116). 
Conversely, pancreatic islet tumor N134 cells ectopically expressing RHAMM showed 
that RHAMM promotes tumor growth independent of cell proliferation(117). Staining of 
uninfected cells and RHAMM-expressing tumor cells with a proliferation marker, Ki67, 
demonstrated that RHAMM-expressing cells were less proliferative than controls 
suggesting an inhibitory affect of RHAMM overexpression on cell growth (117). 
In certain cell backgrounds, however, RHAMM was shown to have no effect on cell 
proliferation. Overexpression of RHAMM is known to promote breast cancer progression 
(94, 118). RHAMM knockdown studies in an aggressive breast cancer cell line, MDA-
MB-231 show no effect of RHAMM loss on cell proliferation, however, it does inhibit 
cell migration and invasion (119). This suggests that RHAMM functions in breast cancer 
progression is unrelated to cell proliferation, but rather is essential during migration and 
invasion. Likewise, stable expression of shRNA to RHAMM in 2884 malignant 
peripheral nerve sheath tumor (MPNST) cell line had no effect on cell proliferation in 
comparison to controls (120).  
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Taken together, this data suggests that RHAMM’s role during cell proliferation is context 
and cell type dependent. 
 
1.8 RHAMM and cell migration 
 
Given RHAMM’s role in regulation of microtubule structures and centrosomes, it is not 
surprising that RHAMM also plays an essential role during non-mitotic functions, such as 
cell motility. Similar to its role in mitosis, RHAMM functions during cell migration are 
mediated by its interactions with its binding partners, including ERK1,2, HA, and 
centrosomes. 
ERK1,2 signaling pathway has been shown to play extensive roles during cell migration 
and in regulating cell protrusion, both initiation and speed  (64, 121). RHAMM is 
required to sustain activation of ERK1,2 and thus its localization and function (88). 
RHAMM-/- fibroblasts exhibit defects in cell migration characterized by failure to 
resurface scratch wounds due to slower speeds and loss of directionality compared to 
RHAMM expressing fibroblasts, and these effects have been shown to be due to loss of 
ERK activation (64). Genetic deletion of RHAMM also resulted in decreased activation 
of ERK1,2 in the nucleus and cell lamellae, which is required for cell protrusion (64). 
Defects in ERK1,2 activity and cell migration can be rescued by expression of full length 
RHAMM or by an activated form of MEK1. Consistently, a MEK inhibitor blocks 
serum-induced motility of RHAMM expressing fibroblasts (64). These results 
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collectively suggest a role for RHAMM-MEK/ERK interactions in regulating cell 
migration.  
RHAMM/HA interactions also play a role in directing cell migration of both transformed 
and non-transformed cells including endothelial cells and bovine aortic SMCs (122, 123). 
HA stimulation increases cell migration of ras transformed fibroblasts and arterial 
smooth muscle cells (ASMCs) in a dose dependent manner and this effect is independent 
of cell proliferation (122, 123). Cell migration in HA-induced ASMCs is dependent on 
RHAMM as knockdown of RHAMM via siRNA inhibits cell motility. Mutation of the 
HA-binding site of RHAMM also reverted the Ras-induced transformation of 10T1/2 
fibroblasts (95). Furthermore, studies using RHAMM function blocking antibodies have 
inhibited HA-stimulated motility in a number of cell lines (64, 67).  RHAMM/HA 
interactions also mediate activation of Rac1 via a PI3K dependent mechanism, which 
promote the formation of actin rich lamellipodia and stress fibers that promote membrane 
protrusions and contraction, respectively, during cell motility (123).   
Furthermore, centrosomes are known to play an integral role during cell migration as they 
help polarize the cytoskeleton (84). Centrosome loss or damage disrupts directed cell 
motility due to loss of cell polarization (42), and thus strict control of the number, 
structure, and position of the centrosome is critical.  RHAMM localizes to centrosomes 
via a carboxyl terminal leucine zipper domain (19). RHAMM plays a role in controlling 
the position and function of centrosomes and accurate rear polarization during cell 
migration in neointimal smooth muscle cells (SMCs) (124), the latter of which is 
dependent on PKCα activity (124). Silencing of RHAMM via siRNA treatment in 
neointimal SMCs results in a shift from rear polarization to front polarization of the 
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MTOC and slow migrating cells compared to control treated cells (slow closing of the 
scratch wound) (124). RHAMM also plays a role in the organization of the actin and 
microtubule network during cell migration; silencing of RHAMM results in fragmented 
lamellipodia and an increase in the number of stable microtubules in the perinuclear 
region (124). Dynamic microtubules are required for cell locomotion as they assist in the 
retraction of the rear end of the cell (40). Furthermore, removal of the centrosome from a 
polarized cell results in changes in the actin and microtubule cytoskeletal networks, 
which give rise to a non-polarized phenotype (42).  These results suggest that RHAMM 
plays a role in regulating centrosome function during cell migration via organization of 
cytoskeletal components to give rise to a polarized cell. These results further hypothesize 
that RHAMM regulation of centrosome function could attribute to the defects seen in 
migration in RHAMM-/- fibroblasts (64). 
 
1.9 The role of RHAMM in cancer 
 
RHAMM overexpression has been implicated in a number of human cancers, including 
breast cancer, multiple myeloma, prostate cancer, hepatocellular carcinomas, colorectal 
cancer, ovarian cancer, and acute myeloid leukemia (79, 92, 118, 125-128). RHAMM is a 
novel breast cancer susceptibility gene and high protein and mRNA expression of 
RHAMM have been correlated with increased peripheral metastasis and poor outcome in 
breast cancer patients (118). 
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In experimental models, RHAMM overexpression is required for maintaining Ras 
transformation through an HA dependent manner. Mutation of the HA binding region of 
RHAMM reverts H-ras transformation (95) suggesting that RHAMM effects on 
transformation are in part mediated through HA. As well, overexpression of RHAMMΔ163 
isoform transforms 10T1/2 mesenchymal cell lines and these form metastatic tumors in 
xenograft models, strongly suggesting that RHAMM is an oncogene (95). Consistent 
with its oncogenic potential, RHAMM mRNA and protein levels are downregulated by 
the tumor suppressor, p53 (48). 
RHAMM functions during tumorigeneis, however, are not fully elucidated. This is in part 
due to the multifunctional roles of RHAMM regulation on the cell surface and within 
intracellular compartments and both play a role in cancer progression.  
Cell surface RHAMM functions as a co-receptor for CD44 and upon binding hyaluronan 
mediates sustained activation of ERK1,2 kinase in MDA-MB-231 breast cancer cell lines 
(94). HA-dependent ERK activation results in increased cell migration and invasion, 
contributing to the oncogenic effects of this protein (94).  
Intracellular RHAMM regulation of mitotic spindle integrity and centrosome function 
provides a putative mechanism by which RHAMM overexpression promotes genomic 
instability and contributes to tumorigenesis. Consistent with this hypothesis, unregulated 
RHAMM expression has been shown to correlate with genomic instability in multiple 
myeloma (92) 
Furthermore, RHAMM functions in mitotic spindle integrity are regulated in part by the 
BRCA1/BARD1 complex (73, 78). RHAMM and BRCA1/BARD1 interactions are seen 
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in numerous mammalian cell lines and together they regulate centrosome amplification 
(78). BRCA1/BARD1 complex regulates the levels of RHAMM via its ubiquitin E3 
ligase activity (73, 78). Overexpression of RHAMM in the absence of BRCA1/BARD1 
results in disrupted mitotic spindle assembly (73). 
It is well established that a loss-of-function mutation in BRCA1 increases susceptibility 
to breast and ovarian cancers (78). Taken together, BRCA1 mutations along side 
RHAMM overexpression thus have the potential to promote genomic instability and 
contribute to breast cancer progression. 
 
1.10 Hypotheses and Objectives  
 
Given the importance of RHAMM in binding to and regulating mitotic spindle integrity, 
microtubules, and centrosome structures, I hypothesized that RHAMM leucine zipper 
maintains mitotic spindle integrity through its direct interactions with tubulin 
heterodimers. 
Furthermore, I hypothesized that RHAMM regulation of centrosome structures controls 
cell polarity and impacts directional migration via its leucine zipper motif. 
The objectives for this dissertation were as follows: 
1) Examine the role of the leucine zipper of RHAMM in direct binding to tubulin, in 
vitro 
39 
 
2) Determine the consequences of a mutated leucine zipper motif of RHAMMΔ163 on 
mitotic spindle functions and tumorigenesis 
3) Determine the effects of a mutated leucine zipper motif of RHAMMΔ163 on 
directed cell migration and centrosome function 
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Chapter 2  
2 Materials and Methods 
 
Cell culture 
The 10T1/2 mouse embryonic fibroblast (MEF) cell line was purchased from American 
Type Culture Collection (ATCC; Manassas, VA, USA). RHAMM knockout (-/-) primary 
mouse embryonic fibroblasts (MEFs) were isolated as described by Tolg et al., 2003 and 
2006 (64, 76).  Cell lines were grown as monolayers in low glucose Dulbecco’s Modified 
Eagle Medium (DMEM) (Wisent BioProducts, Montreal, QC, Canada) supplemented 
with 10% fetal bovine serum (FBS) (Wisent BioProducts) and 1x antibiotic-antimycotic 
(Invitrogen, Life Technologies, Burlington, ON, Canada) in a humidified atmosphere of 
5% CO2 at 37°C. Cells were grown to 80% subconfluency prior to passage and were 
released from tissue culture plastic with 0.25% trypsin-EDTA (Invitrogen, Life 
Technologies).  
 
RHAMMΔ163 mutant constructs  
Mouse RHAMMΔ163 isoform (aa163-794) was used for this dissertation. A RHAMM Δ163 
with a C-terminal leucine zipper mutation was previously constructed in our lab by 
altering the three leucine amino acids in the leucine zipper region using site directed 
mutagenesis. The following mutations were made: Mutation 1—L735R/L742R and 
Mutation 2—L728A/L735R/L742R. Wildtype and mutant RHAMMΔ163 were amplified 
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by PCR with a 5’Sal I site  (FW primer: 5’ 
GGATCAGTCGACATGAGAGCTCTAAGCCTGGAATTGATGAACT 3’) and a 3’ 
Bam HI site (RV primer: 5’ CCCGGATCCTCAGCAGCAGTTTGGGTTGCC 3’) using 
Phusion High Fidelity DNA polymerase (New England Biolabs, Whitby, ON, Canada) as 
recommended by the manufacturer.  Blunt PCR products were then purified using DNA 
Gel Extraction Kit (Bio Basic Inc, Markham, ON, Canada) and cloned into pCR-Blunt 
vector using Zero Blunt PCR Cloning Kit (Invitrogen, Life Technologies), as per the 
manufacturer’s instructions. After enzymatic digestion of both cDNA and vector with Sal 
I and Bam HI restriction enzymes (New England Biolabs), cDNA was ligated into 
pHβApr-1-neo expression vector under the control of the β-actin promoter. The construct 
was sequenced at Robarts Sequencing Facility (Western University, London, ON, 
Canada) and transfected into 10T1/2 MEFs.  
 
RHAMM expression in 10T1/2 and RHAMM-/- MEFs 
Untagged wildtype and mutant RHAMMΔ163 constructs were transfected in 10T1/2 and 
RHAMM-/- (KO) MEFs using jetPrime transfection reagent (jetPrime Polyplus, New 
York, NY, USA), as per the manufacturer’s instructions. Immortalized 10T1/2 and KO 
MEFs were grown in a 6-well plate to a confluency of 70-80% in DMEM supplemented 
with 10% FBS and 1x antibiotic-antimycotic. The plasmid DNA was diluted with 
jetPrime buffer (jetPrime Polyplus) and incubated with transfection reagent at a ratio of 3 
µg DNA: 7 µl transfection reagent. The transfection mix was then slowly added to the 
cells and incubated for 4 hours, after which the media was replaced and incubated 
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overnight. Stable cell lines were established in 10T1/2 and KO fibroblasts by selecting 
for a mixed pool of transfectants with 1-5 mg/ml G418 (Sigma-Aldrich, St. Louis, MO, 
USA).  
 
DNA isolation 
Wildtype and mutant 10T1/2-RHAMMΔ163 cells were harvested by trypsin, washed twice 
with PBS, and then digested overnight at 56°C at 1000rpm on a thermomixer with 18µl 
of 10mg/ml proteinase K in 500 µl of lysis buffer containing 1M Tris (pH 8), 0.5M 
EDTA (pH 8), 10% SDS, and 5M NaCl. After overnight incubation, the cells were 
suspended thoroughly by vortexing and subsequently centrifuged for 10 min at 
13000rpm. Supernatant was collected and added to a new eppendorf tube containing 
500µl isopropanol to precipitate the DNA. Following thorough mixing, the cells were 
centrifuged for 5 min at 13000rpm and supernatant was discarded. The DNA pellet was 
washed with 500µl of 70% ethanol and then centrifuged for 5 min at 13000rpm. The 
supernatant was discarded and the DNA was left to air dry at room temperature overnight 
and then resuspended in 50µl ddH2O for further analysis. DNA from a sample of tumor 
tissue from xenograft studies weighing ~200mg was also obtained using the same 
method.  
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DNA sequencing 
DNA was isolated as above and amplified by PCR using primers spanning an intron-exon 
boundary to amplify ~200 bp region of exogenous RHAMM. The following RHAMM 
primers were used: FW: 5’ AAACCTTTTCAGCAACTGGAT 3’ and RV:  5’ 
AGATCGGAGTTTTGACACCTC 3’ and PCR was carried out using Phusion High 
Fidelity DNA polymerase (New England Biolabs) as recommended by the manufacturer. 
PCR products were then purified using DNA Gel Extraction Kit (Bio Basic Inc.) and 
cloned into pCR-Blunt vector using Zero Blunt PCR Cloning Kit (Invitrogen, Life 
Technologies), as per the manufacturer’s instructions. The samples were then sent to 
Robarts Sequencing Facility (Western University, London, ON, Canada) to be sequenced 
using M13 forward and reverse primers.   
 
Direct and competitive tubulin ELISA  
Biotinylated and unlabeled C-terminal RHAMM peptides (aa720-750) containing the 
leucine zipper, both wildtype and L735R mutant, were synthesized by CanInc Peptide 
(Montreal, QC). Interactions between RHAMM peptides and >99% purified bovine α/β-
heterodimeric tubulin protein (Cytoskeleton, Denver, CO, USA) were detected using a 
direct and competitive tubulin ELISA assay (Figure 2.1). Wells of a 96-well microplate 
(non-TC treated) (Sigma-Aldrich) were coated with 10 µg/ml of α/β-heterodimeric 
tubulin protein (Cytoskeleton) diluted in PBS overnight at 4°C. Control wells with no 
tubulin were coated with PBS. Wells were washed 3-10 minutes with 0.01% Tween-20 in 
PBS and blocked with 5% skim milk in PBS for 2 hours at room temperature. After 
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washing 3 times with 0.01% Tween-20 in PBS, wells were incubated with 5-40 µg/ml of 
either wildtype or L735R mutant biotinylated RHAMM peptides diluted in sterile dH2O 
for 2 hours at room temperature. After two hour incubation with labeled peptides, for 
competitive ELISA assay, 100 µg/ml of unlabeled wildtype RHAMM peptide (diluted in 
water) was mixed into the wells containing 10 µg/ml biotinylated peptides and incubated 
overnight at 4°C. After thorough washing, wells were incubated with streptavidin 
conjugated with horseradish peroxidase (HRP) (Abcam, Cambridge, MA, USA), diluted 
at 1:2000 in PBS for 1 hour at room temperature. Wells were washed for a final 3-10 min 
with 0.01% Tween-20 in PBS and the interaction was detected by incubation with 1-
STEP ABTS (2,2'-azinobis [3-ethylbenzthiazoline-6-sulfonic acid] diammonium salt) 
solution (Thermo Scientific, Waltham, MA, USA) for 20 min, as per the manufacturer’s 
instructions. The reaction was halted by the addition of 1% SDS and absorbance readings 
were measured at 405 nm using the Wallac 1420 VICTOR2 plate reader (PerkinElmer, 
Waltham, MA, USA). Three biological replicates were used per treatment. Control wells 
with no tubulin and no peptide served as the background control.  
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Figure 2.1: Direct tubulin ELISA-assay 
Schematic representation of the novel tubulin ELISA assay generated for testing direct 
RHAMM peptide and tubulin interactions in vitro. Wells were coated with 10µg/ml of 
tubulin heterodimers and incubated with biotinylated RHAMM peptides, either wildtype 
or mutant. Binding was detected via direct interactions between biotin and streptavidin, 
the latter of which is HRP conjugated to allow for the subsequent enzymatic conversion 
of ABTS substrate into a measurable fluorescent product 
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RNA isolation  
10T1/2 parental fibroblasts, as well as stably transfected wildtype and mutant 
RHAMMΔ163-fibroblasts were plated on 10 cm tissue culture plastic in DMEM 
supplemented with 10% FBS. When plates reached 80% subconfluency, total RNA was 
isolated from cells using TRIzol Reagent (Invitrogen, Life Technologies) as per the 
manufacturer’s instructions, and RNA concentrations were determined by absorbance at 
260nm.Three biological replicates were used.  
 
cDNA synthesis and quantitative real-time PCR 
Quantitative real-time PCR (qRT-PCR) was used to verify the overexpression of 
wildtype and mutant RHAMMΔ163 that are stably expressed in 10T1/2 fibroblasts. 1 µg of 
total RNA was used to prepare a 20µl reaction volume of cDNA using Random Primers 
(Invitrogen, Life Technologies) in a first strand cDNA synthesis reaction using 
Superscript II Reverse Transcriptase (Invitrogen, Life Technologies) as per the 
manufacturer’s instructions. Primers for qPCR were designed to amplify a 200 bp region 
of mouse RHAMM and were synthesized by Invitrogen (Pleasanton, CA, USA) and 
amplification of 28S RNA was used for normalization. The following primers were used: 
RHAMM FW: 5’ GTTTCAATAGAGAAAGAAAAGATC 3’; RHAMM RV: 5’ 
CCTCAAGAGACTGCTTAAGAC 3’; 28S FW: 5’ TCATCAGACCCCAGAAAAGG 
3;; 28S RV: 5’ GATTCGGCAGGTGAGTTGTT 3’. qPCR amplification was performed 
on a Stratagene Mx3000P instrument (Agilent Technologies, Mississauga, ON, Canada) 
with SYBR Green QRT-PCR Master Mix (Agilent Technologies) and the reactions were 
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set up as per the manufacturer’s instructions provided for the master mix. The following 
cycle conditions were used: 3 min at 95°C, 20 sec at 95°C, 20 sec at 60°C, 1 min at 95°C, 
30 sec at 60°C, and 30 sec at 95°C. Relative expression levels were calculated by the 
standard curve method and analyzed using Stratagene Mx3000P software as well as 
Microsoft Excel. 
 
Western blot of RHAMM protein expression 
Parental 10T1/2 MEFs and wildtype or mutant 10T1/2- RHAMMΔ163 cells were washed 
twice with cold PBS and then lysed with RIPA Buffer (Sigma-Aldrich) as per the 
manufacturer’s instructions. Cells were detached from the dish with a cell scraper and 
collected via centrifugation at 8000xg for 10 min at 4°C. Protein concentration from the 
cell supernatant was measured using Pearson’s Modification of Micro Lowry Total 
Protein Kit (Sigma-Aldrich). 10µg of protein were loaded and separated onto 10% SDS-
PAGE gels and transferred to a PDVF membrane (Millipore, Billerica, MA, USA). 
Membrane was subsequently blocked for 1 hr at room temperature in 10% skim milk in 
TBS-T (50mM Tris base pH 7.5, 150mM NaCl and 0.05% Tween-20). After washing 
once with TBS-T, membrane was incubated with rabbit anti-RHAMM monoclonal 
antibody (Epitomics, Burlingame, CA, USA) at a dilution of 1:500 in TBS-T containing 
0.5% skim milk overnight at 4°C.  Membrane was then washed 4-10 minutes with TBS-T 
followed by an incubation with anti-rabbit horse radish peroxidase conjugated (HRP) 
secondary antibody at a dilution of 1:100000 in TBS-T containing 0.5% skim milk for 1 
hour at room temperature. After thorough 3-30min washes with TBS-T, the membrane 
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was developed using the Enhanced Chemiluminescence (ECL) detection kit (GE 
Healthcare, Mississauga, ON, Canada). Levels of endogenous full length RHAMM 
(RHAMMFL) served as the loading control as the RHAMM antibody detects both 
RHAMMFL and RHAMMΔ163 forms.  
 
Quantification of cell proliferation  
Parental 10T1/2 and KO MEFs and those stably expressing untagged wildtype or mutant 
RHAMMΔ163 cells were seeded at 1000 cells/well in a 96-well plate. Cells were incubated 
overnight in DMEM supplemented with 10% FBS. After 24 hours, 1/10th of alamarBlue 
reagent (Invitrogen, Life Technologies) was added to wells per cell line and incubated for 
5 hours in a humidified atmosphere of 5% CO2 at 37°C. Cell proliferation was assessed 
over the duration of 96 hours using this method. Fluorescence readings were measured at 
580nm on the Wallac 1420 VICTOR2 plate reader (PerkinElmer). Nine biological 
replicates were used per cell line.  
 
Flow cytometry 
Parental 10T1/2 MEFs and 10T1/2 MEFs stably expressing wildtype and mutant 
RHAMMΔ163 were seeded at 106 cells in 10 cm culture plates and allowed to adhere 
overnight in DMEM supplemented with 10% FBS. Cells were released from tissue 
culture plastic with 0.25% trypsin-EDTA (Invitrogen, Life Technologies) and harvested 
at 1500 rpm for 5 minutes. Cell pellets were then suspended in 500 µl cold PBS and fixed 
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by drop wise addition of 1.5 ml of 90% ethanol while vortexing at a slow speed setting. 
After incubating fixed cells on ice for an hour, cells were centrifuged at 1500 rpm for 5 
min and supernatant was discarded. Cells were then suspended in 1 ml of 2N HCl/0.5% 
Triton X-100 dropwise with gentle vortexing and incubated at room temperature for 30 
min. Cells were pelleted at 1500 rpm for 5 min and then resuspended in 1 ml of 0.1M 
sodium tetraborate (NaB4O7) (pH 8.5). After pelleting cells at 1500 rpm for 5 min and 
washing with PBS, cells were stained with 1 ml of PBS with 1% FBS and 200 µl of 
1mg/ml stock of propidium iodide (Sigma-Aldrich) with 100 µl of 20mg/ml stock of 
DNase-free RNase A (Invitrogen, Life Technologies) and stored overnight at 4°C. 
Stained cells were detected using a flow cytometer (Beckman Coulter, Mississauga, ON, 
Canada) using FACS Calibur with Cell Quest acquisition. Viable cells were gated based 
on forward and side scatter (FSC and SSC, respectively) to eliminate cell debris. Cell 
cycle analysis was then conducted on single cell populations at 20,000 events per sample 
after gating out doublets. Analysis was performed on FlowJo software (Treestar, 
Ashland, OR, USA) and percentages of cells at different stages of the cell cycle were 
calculated using the Watson (Pragmatic) model on FlowJo.  
 
Quantification of cell apoptosis 
10T1/2 MEFs stably expressing wildtype and mutant RHAMMΔ163 (L735R and 
L728A/L735R) were seeded at 5000 cells/well in a 96-well plate and allowed to adhere 
overnight in DMEM with 10% FBS. Apoptosis was detected by the presence of mono-
and oligonucleosomes in the cytoplasmic fraction of cell lysates using the Cell Death 
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Detection ELISAPLUS kit (Roche Applied Science, Indianapolis, IN, USA) as per the 
manufacturer’s instructions. The kit detects apoptosis in cell lysates using anti-histone 
and anti-DNA antibodies. Absorbance readings were measured at 405 nm using the 
Wallac 1420 VICTOR2 plate reader (PerkinElmer) and four biological replicates were 
used per cell lysate. 
 
Tumor xenografts 
10T1/2 MEFs stably expressing wildtype or mutant RHAMMΔ163 were seeded in tissue 
culture plates to reach 80% confluency in complete DMEM supplemented with 10% 
FBS. Cells were released from tissue culture plastic with 0.25% trypsin-EDTA 
(Invitrogen, Life Technologies) and resuspended in complete DMEM supplemented with 
10% FBS prior to cell counting via a hemocytometer. After cell counting, 2 million cells, 
per mouse to be injected, were resuspended in a 50µl total volume of low glucose DMEM 
with 50% volume of Matrigel Basement Membrane Matrix (BD Biosciences, 
Mississauga, ON, Canada). Cells were then subcutaneously injected in the flank of 5-
week-old female NSG mice ordered from The Jackson Laboratory (Bar Harbor, Maine, 
USA). Mice were monitored for tumor growth for 6 weeks and tumors were excised and 
weighed. Three replicate mice were used per cell line to be injected.  
 
 
 
51 
 
Cell migration  
KO- RHAMMΔ163 and KO- RHAMMΔ163-L735R cells were grown to confluent 
monolayers overnight in 12.5cm2 tissue culture flasks (Falcon®, VWR, Mississauga, ON, 
Canada).  Cell monolayers were scratched with a sterile 1250µl pipette tip and media was 
replaced with fresh DMEM supplemented with 10% FBS and allowed to recover in a 
humidified atmosphere of 5% CO2 at 37°C for 30 min. Wound closure was filmed on a 
Nikon TE300 Inverted Microscope (Nikon, Melville, NY, USA) overnight and time-lapse 
images were captured every 5 min. Number of cells that migrated in the wound post-
scratch were counted using ImageJ grid analysis software and the average number of 
cells of three wounded areas were quantified.  
 
Pericentrin immunofluorescence  
KO MEFs and those stably expressing RHAMMΔ163 and RHAMMΔ163–L735R were 
seeded to confluency at 55000 cells/well on coverslips in a 24-well plate and allowed to 
attach overnight. After overnight culture, cell monolayers were scratched with a sterile 
1250µl pipette tip and media was replaced with fresh DMEM supplemented with 10% 
FBS and incubated in a humidified atmosphere of 5% CO2 at 37°C for 6 hours. 
Coverslips were then fixed gently with fresh 3.5% paraformaldehyde for 7 min at room 
temperature. After washing 3 times with 1X buffer (10X buffer: 0.1M Tris pH 7.5, 1.5M 
NaCl, 1% BSA), cells were permeabilized with 0.2% Triton X-100 in 1X buffer for 5 min 
at room temperature and then blocked with 1X buffer for 5 min at room temperature. 
Cells were then incubated with rabbit polyclonal anti-pericentrin antibody (Abcam) 
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diluted at 1:1200 in 1X buffer for 30 min in a humidified atmosphere of 5% CO2 at 37°C. 
After washing once in 1X buffer for 5 min, cells were incubated with anti-rabbit Alexa 
Fluor 488 IgG diluted at 1:1000 in 1X buffer for 1 hour at room temperature. Cells were 
washed once with 1X buffer and coverslips were then mounted using Prolong Gold DAPI 
antifade reagent (Invitrogen, Life Technologies) and imaged on the Nikon A1R Confocal 
Laser Microscope (Nikon).  
The percentage of cells with greater than one centrosome at the wound edge were 
quantified; mitotic figures as determined by DNA staining with DAPI, were excluded 
from the count. Furthermore, the location of the centrosome relative to the cell nucleus 
was determined by monitoring the directional movement of cells into the wounded area; 
the percentage of cells with centrosomes behind the nucleus was quantified.  
 
Statistical analysis 
Statistical differences between groups were assessed using two-tailed Student’s t-test. P-
values <0.05 were considered statistically significant.  
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Chapter 3  
3 Results 
3.1 Objective 1: Examining the role of the leucine zipper 
motif in RHAMM-microtubule interactions 
 
Site directed mutagenesis of a leucine zipper interaction motif: Rationale for 
mutations 
Site-directed mutagenesis is routinely used to study the functional consequences of a 
single, point mutation in a protein of interest. To gain a better understanding of the C-
terminal leucine zipper of RHAMMΔ163, mutations were constructed by altering the 
following leucine amino acid residues in the leucine zipper motif: Mutation 1—
L735R/L742R and Mutation 2—L728A/L735R/L742R (Table 3.1-Initial mutations).  
Mutated RHAMMΔ163 cDNAs were prepared and cloned into the pHβ-APr1 mammalian 
expression vector with a neomycin selection marker (Figure 3.1) and mutations were 
confirmed by DNA sequencing. Cloned plasmids containing mutant RHAMMΔ163 cDNA 
were expressed in 10T1/2 MEFs and a pool of mixed transfectants were selected in G418 
to generate stable cell lines. Genomic DNA from 10T1/2 MEFs expressing mutant 
RHAMMΔ163, L735R/L742R or L728A/L735R/L742R, were isolated and sequenced. 
Sequencing results of both mutants revealed a R742L reversion (Table 3.1-Reverted 
mutations) suggesting that this leucine residue is functionally important, yet its 
significance warrants further investigation. Despite the apparent reversion under selection 
pressure, mutation of one hydrophobic leucine residue to a charged arginine residue 
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should be sufficient to abolish leucine zipper dimerization function. Since stable cell lines 
express the reverted sequences, experiments throughout this dissertation were based on 
the reverted RHAMM mutations and referred to as L735R and L728A/L735R. 
 
Table 3.1: RHAMM Leucine Zipper Sequences 
Wildtype Sequence 728 LKDENSQLKSEVSKL 742 
Initial Mutations 
L735R/L742Rà  728 LKDENSQRKSEVSKR 742 
L728A/L735R/L743Rà  728 AKDENSQRKSEVSKR 742 
Reverted Mutations 
L735Rà  728 LKDENSQRKSEVSKL 742 
L728A/L735Rà  728 AKDENSQRKSEVSKL 742 
Sequences represent the carboxyl terminal leucine zipper region of RHAMM from amino 
acid 728 to 742 of the full-length protein. This region of RHAMM is proposed to 
facilitate RHAMM-mitotic spindle interactions in cell culture. Initial mutations, 
L735R/L742R and L728A/L735R/L742R, represent mutations that were generated by 
site-directed mutagenesis to alter the leucine zipper function; mutated amino acid 
residues are outlined in red. Reverted amino acids, obtained after selection for expression 
of initial mutations, are indicated in blue 
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Figure 3.1 RHAMMΔ163 Constructs  
Wildtype and mutant RHAMMΔ163 cDNA were amplified by PCR and cloned into the 
mammalian pHβ-APr1 expression vector in the Sal I and Bam HI sites. The vector is 
driven by the β-actin promoter and contains a neomycin resistant gene for selection of 
stable transfectants in 10T1/2 and RHAMM-/- MEFs 
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RHAMM sequence containing the leucine zipper binds directly to tubulin in vitro 
During mitotis, RHAMM localizes along the length of microtubules and this interaction 
occurs via its carboxyl terminus. Within the C-terminal microtubule binding region is a 
conserved leucine zipper that is thought to mediate RHAMM/mitotic spindle interactions. 
Deletion of RHAMM fragments lacking the leucine zipper disrupts proper spindle 
formation, thus owing to its essential role in maintaining mitotic spindle integrity (19, 73, 
74) 
Our lab has demonstrated that C-terminal RHAMM fragments bind to tubulin 
heterodimers, in vitro, and this interaction can be disrupted by the addition of a 
synthesized peptide containing the leucine zipper motif.  To identify the mechanism by 
which RHAMM associates with the mitotic spindle, we aimed to determine whether 
RHAMM directly interacts with microtubules [tubulin heterodimers] via the leucine 
zipper sequence. Direct interactions between commercially purified α/β-heterodimeric 
tubulin and a C-terminal biotinylated wildtype RHAMM peptide (Table 3.2) containing 
the leucine zipper were tested using an ELISA assay (Figure 2.1). Wildtype RHAMM 
peptide showed specific binding to tubulin heterodimers in a concentration dependent 
manner (Figure 3.2A); background binding was low, and these interactions were 
abolished by competition with excess competitive RHAMM peptide (Figure 3.2B). 
Furthermore, a scrambled peptide of the same amino acid residues showed positive, yet 
nonspecific weak binding as this interaction could not be competed off with excess 
competitive RHAMM peptide (Figure 3.2B). These results support the hypothesis that 
RHAMM-tubulin interactions occur through the conserved C-terminal domain of 
RHAMM and most importantly that these interactions occur directly.  
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Table 3.2: RHAMM Peptide Sequences 
Peptide Sequence 
Wildtype Biotin-AEEA-QKIKHVVKLKDENSQLKSEVSKLRSQLVKRK-NH2 
L735R Biotin-AEEA-QKIKHVVKLKDENSQRKSEVSKLRSQLVKRK-NH2 
Scrambled Biotin-AEEA -LDRLKHVQKNKLSKSQKIVKSKVELRSQEVK-NH2 
Competitive Ac- QKIKHVVKLKDENSQLKSEVSKLRSQLVKRK-NH2 
3.5 kDa RHAMM peptide sequence representing 31 amino acids of the C-terminal 
domain of RHAMM (aa720-750), including the underlined leucine zipper proposed to 
function in binding to the mitotic spindle. Three peptides were biotinylated at the N-
terminus via a short PEG linker (AEEA) to allow for specific binding to streptavidin in 
tubulin ELISA assay. The mutated amino acid residue in the leucine zipper of L735R is 
highlighted in red. Scrambled peptide was generated by randomly rearranging the amino 
acids of the wildtype peptide. Competitive peptide was used for a competitive ELISA 
assay and was unlabeled but acetylated at the N-terminus end 
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Figure 3.2: Wildtype and mutant C-terminal RHAMM peptides directly bind to α-, 
β-tubulin heterodimers in an ELISA assay 
Direct and competitive tubulin ELISA assays were performed using purified α/β-tubulin 
heterodimers and biotinylated C-terminal RHAMM peptides (aa 720-750) A) Direct 
binding interactions of wildtype and mutant RHAMM peptides to tubulin were detected 
in a concentration dependent manner B) Binding of biotinylated wildtype and mutant 
RHAMM peptides to tubulin heterodimers was competed off with excess unlabeled 
wildtype RHAMM peptide (aa 720-750). Scrambled peptide was not able to compete off, 
confirming the specificity of the C-terminal RHAMM sequence to tubulin. Bars represent 
mean ± S.E. of n=3 replicates; *p<0.05  
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Mutation of the leucine zipper does not affect RHAMM binding to tubulin in vitro 
The ELISA data confirmed the specific interaction of wildtype C-terminal RHAMM 
peptide with tubulin heterodimers. To determine the role of the leucine zipper in this 
interaction, a RHAMM peptide containing mutation L735R of the leucine zipper was 
synthesized (Table 3.2) and its binding to tubulin was tested.  A leucine zipper is a 
common protein-protein interaction motif that contains heptad repeats of hydrophobic 
leucine residues, which form amphipathic α helices used for parallel dimerization with 
other proteins (129). Typically, the mutation of one leucine residue disrupts leucine 
zipper function and thus the ELISA assay was only carried out for one mutant RHAMM 
form. Mutating one leucine residue, L735R, in RHAMM’s leucine zipper, however, did 
not disrupt binding to tubulin; under these conditions the L735R peptide retained an 
ability to bind to tubulin in a concentration dependent manner (Figure 3.2A) and wildtype 
unlabeled peptide was able to compete for its binding (Figure 3.2B). These results 
demonstrate that although the C-terminal RHAMM sequence contained within this 
peptide mediates direct binding to tubulin heterodimers, these interactions were not 
through the leucine zipper dimerization motif, as disruption of its function did not abolish 
binding to tubulin.  
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3.2 Objective 2: Assessing the role of RHAMMΔ163 in mitotic 
spindle functions and tumorigenesis 
 
Overexpression of wildtype and mutant RHAMMΔ163 in fibroblasts does not 
promote cell proliferation to similar extents 
Our in vitro data confirmed that RHAMM binds directly to tubulin via its carboxy 
terminal domain and that the leucine zipper motif does not mediate this binding. To 
determine if this interaction was retained in cell culture and if leucine zipper mutations 
abolished RHAMM/mitotic spindle interactions, GFP-tagged RHAMMΔ163, both 
wildtype and mutant forms, were expressed in 10T1/2 cell lines. Interestingly, expression 
of GFP fusion proteins under a strong CMV promoter resulted in cell death; hence we 
were unable to obtain stable transfectants. GFP fusion proteins were thus expressed under 
the β-actin promoter to reduce deleteriously high RHAMM expression. Stable 
transfectants were selected for with G418, however, under selection pressure few G418-
resistant colonies showed any detectable green fluorescence and expression rapidly 
declined. As an alternate approach, transient expression of GFP- RHAMMΔ163 was used, 
however, this resulted in too low of an expression to be useful. Thus assessing the direct 
effects of mutant RHAMMΔ163 expression on mitotic spindle interactions in culture 
proved to be difficult using this approach.    
As an alternative method, cellular events that are relevant to mitotic spindle formation 
were used as surrogate markers to indirectly assess if RHAMM/mitotic spindle 
interactions were perturbed. Based on previous publications, we assumed that leucine 
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zipper mutations would abolish RHAMM/mitotic spindle interactions and that cellular 
events including cell proliferation, cell cycle progression, and apoptosis would be altered.  
Overexpression of RHAMM mRNA and protein levels was first confirmed in established 
stably transfected 10T1/2 cell lines by qPCR and western blot analysis, respectively. 
10T1/2 parental MEFs express low levels of endogenous RHAMM forms, including 
RHAMMΔ163 and full-length RHAMM (RHAMMFL). RHAMM mRNA expression in 
10T1/2- RHAMMΔ163, 10T1/2- RHAMMΔ163-L735R, and 10T1/2- RHAMMΔ163-
L728A/L735R cells were significantly higher than parental 10T1/2 fibroblasts, with a 
~2.6-2.8 fold increase in expression (Figure 3.3A, B). Western blot analysis displayed a 
similar expression pattern with parental 10T1/2 fibroblasts displaying low levels of 
endogenous RHAMMΔ163 compared to wildtype and mutant 10T1/2- RHAMMΔ163 
expressing cells, which displayed higher levels of ectopic RHAMMΔ163. Levels of 
endogenous RHAMMFL served as the loading control (Figure 3.4).  
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Figure 3.3: mRNA expression levels of RHAMM in 10T1/2 MEFs 
10T1/2 MEFs were transfected with RHAMMΔ163, RHAMMΔ163-L735A, or 
RHAMMΔ163-L728A/L735R, and a mixed pool of transfectants were selected for using 
G418. cDNA from parental 10T1/2 MEFs and 10T1/2 MEFs stably expressing wildtype 
or mutant RHAMMΔ163 were analyzed by qRT-PCR using RHAMM specific primers. 
Relative expression levels of the RHAMM gene were determined using the standard 
curve method with expression normalized to 28S mRNA. A) 10T1/2 MEFs expressing 
RHAMMΔ163 and L728A/L735R showed a 2.8 and 2.6 fold increase in RHAMM 
expression, respectively, compared to control 10T1/2 MEFs which express low levels of 
endogenous RHAMM B) 10T1/2 MEFs expressing L735R showed a 2.8 fold increase in 
RHAMM expression compared to control 10T1/2 MEFs. Data represents the mean of 
n=3 replicates ±S.E; *p<0.05 
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Figure 3.4: RHAMMΔ163 protein levels in 10T1/2 fibroblasts 
10T1/2 MEFs were transfected with w RHAMMΔ163, RHAMMΔ163-L735A, or 
RHAMMΔ163-L728A/L735R, and a mixed pool of transfectants were selected for using 
G418. Whole cell lysates were prepared and analyzed by western blotting. RHAMMΔ163 
protein expression was determined by hybridization with a monoclonal RHAMM 
antibody recognizing sequences in the N-terminus. As expected, 10T/12 parental cells 
express low levels of endogenous RHAMMΔ163 compared to ectopic overexpression of 
RHAMMΔ163 in established stable 10T1/2 cell lines. Expression of endogenous full-
length RHAMM (RHAMMFL) was used as a loading control as this form is detected 
using the same RHAMM antibody 
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The first aim was to determine whether ectopic overexpression of RHAMMΔ163 promoted 
cell proliferation in 10T1/2 MEFs by using the innate reducing ability of cells to convert 
exogenously added alamarBlue reagent, resazurin, into a measurable fluorescent product, 
resorufin. Results unexpectedly showed that the proliferation of 10T1/2-RHAMMΔ163 
fibroblasts was significantly reduced over the duration of 96 hours compared to 10T1/2 
parental MEFs. The greatest difference in proliferation was seen at 48 and 72 hours post 
cell plating (Figure 3.5A).  
RHAMM-/- fibroblasts provide a cleaner system to study the effects of RHAMMΔ163 on 
cell proliferation since they lack endogenous RHAMM. Similar to 10T1/2 MEFs, stable 
overexpression of RHAMMΔ163 in RHAMM-/- cells showed a decrease in cell 
proliferation (Figure 3.6A).  
Overexpression of RHAMMΔ163-L735R or RHAMMΔ163-L728A/L735R in 10T1/2 MEFs 
similarly decreased proliferation when compared to parental fibroblasts (Figure 3.5B). 
However, they did not alter proliferation when compared to RHAMMΔ163; L735R growth 
was not significantly different from RHAMMΔ163, while L728A/L735R expressing 
fibroblasts showed a subtle, yet significant, increase in proliferation at 24, 48, and 72 
hours, though the significance of these results were variable between experiments (Figure 
3.5C). Furthermore, expression of L735R mutant in RHAMM-/- (KO) cells showed 
significant, yet minor affects on cell proliferation compared to RHAMMΔ163 expressing 
cells (Figure 3.6B).  
Collectively, these results demonstrate that overexpression of RHAMMΔ163 inhibits rather 
than stimulates proliferation of 10T1/2 and RHAMM-/- fibroblasts and disrupting the 
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leucine zipper does not further affect this function.  However, expression of 
RHAMMΔ163-L728A/L735R significantly increased proliferation compared to 
RHAMMΔ163 suggesting a plausible role for specific leucine residues, but not a leucine 
zipper function in RHAMM effects on proliferation. 
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Figure 3.5: Overexpression of wildtype and mutant RHAMMΔ163 in 10T1/2 
fibroblasts does not promote cell proliferation  
Cell proliferation of parental 10T1/2 MEFs and 10T1/2 fibroblasts expressing 
RHAMMΔ163, RHAMMΔ163-L735R, and RHAMMΔ163-L728A/L735R was assessed by 
alamarBlue reagent. A) Overexpression of RHAMMΔ163 in 10T1/2 MEFs decreases cell 
proliferation over the course of 96 hours. B) Expression of RHAMMΔ163-L735R or 
RHAMMΔ163-L728A/L735R, in 10T1/2 MEFs similarly decreases cell proliferation. C) 
Overexpression of RHAMMΔ163-L735R has subtle affects on cell proliferation compared 
to RHAMMΔ163. The results represent mean fluorescence units ±S.E of n=9 replicates. * 
p<0.05 
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Figure 3.6: Expressing RHAMMΔ163 –L735R in RHAMM-/- fibroblasts does not 
drastically alter cell proliferation 
Cell proliferation of KO- RHAMMΔ163 and KO- RHAMMΔ163–L735R cells were assessed 
using alamarBlue reagent. A) Overexpression of RHAMMΔ163 in RHAMM-/- fibroblasts 
results in a decrease in cell proliferation over 96 hours. B) Overexpression of 
RHAMMΔ163-L735R has subtle affects on cell proliferation. The results represent mean 
fluorescence units of n=9 replicates per cell per cell line ±SE *p<0.05 
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Overexpression of wildtype or mutant RHAMMΔ163 does not alter cell cycle 
progression when expressed in 10T1/2 MEFs  
RHAMM expression is tightly regulated during the cell cycle and levels of RHAMM 
peak at G2/M. Mutating the mitotic spindle-binding region of RHAMM would thus be 
expected to impact cell cycle progression. Previous studies have shown that 
overexpression of RHAMM isoforms in certain cell lines results in a mitotic arrest at 
G2/M (19). We therefore first determined if overexpression of RHAMMΔ163, in 10T1/2 
mouse embryonic fibroblasts similarly blocked cell cycle progression.  
Cell cycle profiles of asynchronous 10T1/2- RHAMMΔ163 MEFs, as demonstrated by 
DNA content using PI staining and subsequent flow cytometry, revealed similar profiles 
with distinct G1, S, and G2/M peaks as parental 10T1/2 MEFs at 24 hours post culturing 
(Figure 3.7A,B). The percentage of cells in each stage of the cell cycle did not differ 
significantly between the two populations (Figure 3.7C). Results suggest that a 2.8 fold 
increase in RHAMM mRNA expression was not sufficient to arrest the cells in mitosis.  
Likewise, expression of RHAMMΔ163-L735R or RHAMMΔ163-L728A/L735R did not 
significantly alter 10T1/2 cell cycle progression when compared to either parental cells or 
RHAMMΔ163 expressing fibroblasts. The percentages of cells in the different stages of the 
cell cycle—G1, S and G2/M—were not significantly different between the different 
populations (Figure 3.7C), suggesting leucine zipper mutations do not impact cell cycle 
progression. 
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Figure 3.7: Overexpression of wildtype or mutant RHAMMΔ163 in asynchronous 
10T1/2 fibroblasts does not alter cell cycle progression 
DNA content of asynchronous 10T1/2 parental and 10T1/2- RHAMMΔ163 cells, both 
wildtype and mutant (L735R or L728A/L735R), was stained with propidium iodide and 
analyzed by flow cytometry. Representative histograms of DNA content during the cell 
cycle of A) 10T1/2 parental cells and B) 10T/12- RHAMMΔ163 transfected cells. Grey 
outline of each graph represents the Watson-Pragmatic model of cell cycle analysis C) 
Cell cycle distribution of 10T1/2 parental and 10T1/2 cells expressing RHAMMΔ163, 
RHAMMΔ163-L735R, and RHAMMΔ163-L728A/L735R expressed as a percent obtained 
via the Watson Pragmatic model. Overexpression of RHAMMΔ163 –L735R or 
RHAMMΔ163 –L735R/L728A/L735R had no effect on cell cycle progression. Each 
column represents the mean of n=4 independent experiments ± S.E; n.s indicates no 
statistical significance between 10T1/2 parental cells or 10T1/2- RHAMMΔ163 cells in the 
same phases of the cell cycle, p>0.05 
 
 
 
 
 
 
 
75 
 
Expression of mutant RHAMMΔ163 forms in 10T1/2 MEFs does not affect cell 
apoptosis 
Since RHAMM is known to play a role in mitotic spindle integrity, we speculated that 
mutations in the putative mitotic spindle-binding region would contribute to aberrations 
during spindle assembly. Consequently, an accumulation of defects in mitotic spindle 
assembly has the potential to trigger the apoptotic machinery. To assess if mutations 
made in the leucine zipper of RHAMM would alter the number of apoptotic cells, levels 
of apoptosis of 10T1/2 MEFs stably expressing RHAMMΔ163, L735R or L28A/L735R 
were assessed. The presence of cytoplasmic histone-associated DNA fragments that were 
present after cell death was quantified from cell lysates of both wildtype and mutant 
10T1/2-RHAMMΔ163 cells using ELISA. Expression of L735R or L728A/L735R 
RHAMMΔ163 did not induce changes in apoptosis when compared to RHAMMΔ163 
expressing MEFs (Figure 3.8). This suggests that mutations in the leucine zipper 
sequence of RHAMM do not have an effect on cell death.   
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Figure 3.8: Expression of mutant RHAMMΔ163 forms in 10T1/2 MEFs does not 
affect apoptosis 
Lysates of 10T1/2-RHAMMΔ163, 10T1/2- RHAMMΔ163 -L735R and 10T1/2-RHAMMΔ163 
-L728A/L735R fibroblasts were analyzed 24 hours post seeding to determine levels of 
apoptosis. Cell death was assessed using an ELISA assay detecting mono- and 
oligonucleosomes using anti-histone and anti-DNA antibodies. Each column represents 
the mean absorbance of n=4 replicates ± S.E; n.s indicates no statistical significance from 
RHAMMΔ163, p>0.05 
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Mutant 10T1/2- RHAMMΔ163 expressing fibroblasts retain the ability to form tumor 
xenografts in immune compromised mice 
Our lab has shown that overexpression of RHAMMΔ163 in 10T1/2 mouse embryonic 
fibroblasts results in cell transformation as shown by tumor formation in immune 
compromised mice (95) and this ability has been linked to genomic instability generated 
by aberrant mitosis in multiple myeloma (81). Cell transformation was used as a 
surrogate marker to assess a change in tumor formation if RHAMM/mitotic spindle 
interactions were altered. To determine whether mutant RHAMMΔ163 retains oncogenic 
effects and in turn to assess if a mutated leucine zipper affects the transforming potential, 
10T1/2 MEFs expressing RHAMMΔ163, RHAMMΔ163 -L735R or RHAMMΔ163 -
L728A/L735R were subcutaneously injected in the flank of NSG mice and tumor growth 
was monitored. Both 10T1/2- RHAMMΔ163-L735R and 10T1/2- RHAMMΔ163-
L728A/L735R retain their ability to form tumor xenografts (Table 3.3). Tumors were 
excised and their wet weights determined (see Appendix A). The differences in tumor 
weights, however, could not be compared as tumor-forming capabilities varied between 
experiments.  These results suggest that disruption of the leucine zipper does not have 
strong effects on tumorigenesis as mutant RHAMMΔ163 forms still formed tumor 
xenografts in immune compromised mice.  
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Table 3.3: Summary of transforming abilities of 10T1/2 fibroblasts 
Cell Type Transforming? 
10T parental MEFs NO 
10T Empty Vector NO 
10T RHAMMΔ163 MEFs YES 
10T RHAMMΔ163 –L735R MEFs YES 
10T RHAMMΔ163 –L728A/L735R MEFs YES 
10T1/2 parental and RHAMMΔ163 expressing (wildtype or mutant) fibroblasts were 
subcutaneously injected in the flank of NSG mice and tumor growth was monitored over 
6 weeks. L735R and L728A/L735R fibroblasts retain the ability to transform cells and 
form tumors in mice. Ability to transform is based on tumor formation seen in triplicate 
mice per cell line injected. 10T1/2 parental and 10T1/2 empty vector cells serve as the 
negative controls, while 10T1/2 RHAMMΔ163 served as the positive control 
 
 
 
 
 
79 
 
3.3 Objective 3: Assessing the role of RHAMM Δ163 in 
directed cell migration 
 
Mutant RHAMMΔ163 expression in RHAMM-/- MEFs causes defects in cell 
migration due to loss of directionality 
Tight control of centrosomal function is essential not only for proper cell division, but 
also for directed cell migration. Defects in the function, structure, number, or position of 
centrosomes can contribute to aberrant cell migration and division due to loss of polarity.  
The carboxy terminal leucine zipper of RHAMM is known to function in binding to and 
modulating the position of centrosomes (19, 84). RHAMM also plays an essential role 
during cell migration and its genetic deletion results in an inability of cells to resurface 
scratch wounds with a concomitant decrease in motility rate, which can be rescued by 
RHAMM expression. To determine the effects of L735R-RHAMMΔ163 expression on 
directed cell migration and if these cells were able to rescue the motility defects in 
RHAMM-/- MEFs, we conducted scratch wound assays on RHAMM-/- cells stably 
expressing RHAMMΔ163 or RHAMMΔ163-L735R. This assay assesses the ability of cells 
to move into a cell-free area created by scraping the center of a confluent monolayer of 
cells. Time-lapse analysis of the scratch-wounds revealed significantly fewer mutant 
RHAMMΔ163-L735R cells present in the scratches compared to RHAMMΔ163 cells 
(Figure 3.9A-C).  The differences seen in cell migration were not due to differences in 
cell growth, as expression of RHAMMΔ163-L735R in RHAMM-/- cells did not inhibit cell 
proliferation (Figure 3.6B). These results suggest that a mutation in the leucine zipper of 
RHAMMΔ163 (L735R) impacts the ability to recover scratch wounds. 
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C) 
 
Figure 3.9: RHAMMΔ163 –L735R expression in RHAMM-/- MEFs causes defects in 
cell migration 
Confluent monolayers of RHAMM-/- (KO) MEFs stably expressing RHAMMΔ163or 
RHAMMΔ163-L735R were cultured overnight and subsequently scratched using a sterile 
pipette tip. Wound closure was assessed by time-lapse microscopy at the indicated time 
points at 4x magnification. Images from a representative experiment of A) KO- 
RHAMMΔ163 and B) KO-RHAMMΔ163–L735R at different time points are shown. C) 
Fewer number of KO-RHAMMΔ163–L735R cells migrated into the scratch wound. Data 
represents the mean of three randomized areas of the scratched wound with error bars 
representing standard error. * p<0.05 
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Furthermore, the defects in migration could account for a reduced rate of motility or 
altered directional movement. To identify if RHAMMΔ163-L735R fails to promote speed 
or direction of movement, the motility of individual cells from the scratch wound assays 
were tracked using vector analysis. Results show that RHAMMΔ163-cells migrated further 
distances away from the cell origin compared to RHAMMΔ163-L735R expressing cells 
(Figure 3.10A-C). Whereas RHAMMΔ163 cells migrated into the wound, the 
directionality was disturbed in RHAMMΔ163-L735R cells, which traveled back into the 
monolayer resulting in a decrease in distance migrated from the cell origin (Figure 
3.10C). The L735R mutant did not affect overall distance travelled by the cells and 
therefore did not have a significant impact on rate of motility (Figure 3.10D). Note that 
RHAMM-/- fibroblasts are directionally and speed impaired and these defects are rescued 
by RHAMMΔ163 expression. Thus, mutating the leucine zipper of RHAMMΔ163 rescued 
speed, but did not rescue the directionality defects of RHAMM-/- fibroblasts.     
 
 
 
 
 
 
 
 
83 
 
A) KO- RHAMMΔ163      B) KO- RHAMMΔ163-L735R 
                       
C)       
 
D) 
 
 
0 
50 
100 
150 
200 
250 
KO-RHAMMΔ163 KO-RHAMMΔ163-L735R 
D
is
ta
nc
e 
fr
om
 O
ri
gi
n 
(u
m
) 
  * 
0 
100 
200 
300 
400 
500 
600 
700 
KO-RHAMMΔ163 KO-RHAMMΔ163-L735R 
Pa
th
 L
en
gt
h 
(u
m
) 
      n.s 
84 
 
Figure 3.10: KO-RHAMMΔ163-L735R fibroblasts migrate shorter distances from the 
cell origin  
Confluent monolayers of RHAMM-/- (KO) MEFs stably expressing RHAMMΔ163or 
RHAMMΔ163-L735R were cultured overnight and subsequently scratched using a sterile 
pipette tip. Wound closure was assessed by time-lapse microscopy overnight at 4x 
magnification. The motility of individual cells was tracked using NIS Elements imaging 
software. Representative images of the path of individual A) KO-RHAMMΔ163 and B) 
KO-RHAMMΔ163-L735R- fibroblasts as they migrate into the scratch wounds C) 
Average distance of cells at the wound edge as they travel from cell origin D) Average 
path length fibroblasts traveled from wound edge Mean ±SE, n=10, *p<0.05  
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Percentage of KO-RHAMMΔ163-L735R cells with n>1 centrosome was greater than 
KO- RHAMMΔ163 –rescued cells  
Our results suggested that there was a migration defect when expressing RHAMMΔ163 
mutated in the leucine zipper region. Since this region is known to bind to centrosomes 
and regulates their structure/function, we next determined if centrosome number or 
location within the RHAMMΔ163 –L735R expressing cells was altered. 
 KO, KO-RHAMMΔ163, and KO-RHAMMΔ163-L735R expressing cells were seeded on 
coverslips and confluent monolayers were scratched and allowed to recover before 
staining the cells with a centrosome marker, pericentrin, and DAPI to stain the nucleus. 
Cells at the wound edge were imaged (Figure 3.11A-D) and the number and location of 
centrosomes were quantified. The percentage of non-dividing cells with more than one 
centrosome was greatest in KO- RHAMMΔ163-L735R cells (Figure 3.11E).  Additionally, 
the location of the centrosome with respect to the cell nucleus was altered in KO- 
RHAMMΔ163-L735R cells in that there were a greater percentage of cells with 
centrosomes behind the nucleus; however, it was not significantly different from KO- 
RHAMMΔ163 or KO cells (Figure 3.11F). These results suggest that RHAMM leucine 
zipper may play a functional role in regulating centrosome number, but not in centrosome 
placement/position.   
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F) 
 
Figure 3.11: The percentage of cells with n>1 centrosome is greatest in KO- 
RHAMMΔ163-L735R 
KO, KO- RHAMMΔ163, and KO- RHAMMΔ163-L735R expressing fibroblasts were grown 
to confluency overnight and subsequently scratched using a sterile pipette tip. Cells were 
fixed and stained with the centrosome marker, pericentrin, and DAPI to visualize the 
nucleus. Cells at the wound edge were imaged at 20x magnification and analyzed. 
Representative immunofluorescent images of A) mitotic figures that were not included in 
the analysis, B) KO- RHAMMΔ163-L735R, C) KO- RHAMMΔ163 and D) KO parental 
cells, where green represents pericentrin staining, blue represents DAPI staining, and the 
dashed line represents the wound edge E) The percentage of cells with n>1 centrosome 
was greatest in KO- RHAMMΔ163-L735R cells compared to KO or KO- RHAMMΔ163 
cells.  F) The orientation of the centrosome with respect to the cell nucleus was not 
altered in KO- RHAMM
Δ163
–L735R expressing cells compared to either KO- 
RHAMMΔ163 or parental KO cells. Data represents the percentage of the average number 
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of counted cells: 517 KO, 488 KO- RHAMMΔ163, and 483 KO- RHAMMΔ163-L735R; 
*p<0.05, n.s indicates no statistical significance compared to KO or KO- RHAMMΔ163 
where p>0.05. 
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Chapter 4  
4 General Discussion  
 
4.1 Role of RHAMM in mitotic functions 
 
Several reports have established a role for RHAMM in binding to and regulating mitotic 
spindle integrity (19, 20, 73). During the mitotic phase of the cell cycle, RHAMM 
localizes to the mitotic spindle along the length of microtubules and is particularly 
concentrated at the spindle poles (20, 69, 74). Genetic deletion or inhibition of 
endogenous RHAMM forms results in abnormal mitotic figures with multi-polar mitotic 
spindles (19, 20, 74). Silencing of RHAMM also impacts the kinetics of mitosis and 
results in a delay in spindle assembly and in mitotic completion (100), suggesting a role 
for RHAMM in mediating microtubule assembly. Further experiments reveal that 
RHAMM also impacts positioning of the mitotic spindle and thus helps establish an 
oriented bipolar spindle (93, 100). 
Consistent with RHAMM’s role in regulating mitotic spindle functions, the RHAMM 
gene is cell cycle regulated and its expression increases during G2/M, a stage in the cell 
cycle where a cell prepares for and subsequently undergoes mitosis (4, 111). Blocking 
cell surface or knockdown of intracellular RHAMM forms results in a slower progression 
of cells through G2/M and a fewer percentage of cells at G2/M, respectively (91, 109).  
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Previous literature utilizing deletion constructs of carboxyl terminal RHAMM fragments 
have narrowed down the last 100 amino acid residues containing a leucine zipper motif to 
be essential in localizing RHAMM to mitotic spindles (19). Mutational analysis of the 
leucine residues in the leucine zipper to arginines further revealed that this particular 
region serves a functional role in proper aster spindle formation in Xenopus egg extracts 
and was thus required for mitotic spindle integrity (20, 73, 100). The latter study made 
use of a C-terminal RHAMM peptide corresponding to the leucine zipper that when 
present in excess disrupts aster spindle formation. When mutated in the leucine zipper 
motif, however, the peptide does not display defects in spindle assembly. The effects of 
this regulation were dependent on the presence of BRCA1/BARD1 complex, whose role 
was predicted to safeguard the formation of a bipolar mitotic spindle (73, 78). The 
authors of the study concluded that the leucine zipper motif is therefore functionally 
important in regulating spindle integrity. Results from this study and other works 
showing that deletion of RHAMM has a similar effect on spindle integrity indicates that 
RHAMM levels must be tightly regulated throughout the cell cycle, since its deletion or 
forced high expression results in abnormal mitosis  
The mechanism by which RHAMM mediates spindle pole assembly and regulation is 
complex, involves numerous factors, and not fully understood. The literature, however, 
highlights an important role for the leucine zipper motif within RHAMM’s carboxyl 
terminus in mediating direct and indirect effects via its binding partners.  
Work in our lab has demonstrated a putative mechanism by which the carboxyl terminal 
of RHAMM directly regulates the mitotic spindle and this is through its direct 
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interactions with tubulin heterodimers [microtubules] as this interaction can be competed 
off using a synthesized peptide containing the leucine zipper sequence (20).    
Additionally, several reports have established that RHAMM/centrosome interactions, 
also mediated through the leucine zipper, are essential for mitotic spindle integrity in a 
variety of cell types (19, 84). Mutational analysis of the centrosomal binding region of 
RHAMM not only results in less RHAMM localized around centrosomes, but also 
spindle pole defects characterized by tetrapolar mitotic figures (84).  
Furthermore, recent work has identified a role of RHAMM leucine zipper to be essential, 
although not sufficient, in mediating interactions with the spindle assembly protein 
factor, TPX2. This study also proposed that the major effect of RHAMM on mitotic 
spindle function was mediated by TPX2, which binds to the leucine residues of the 
leucine zipper (73, 100). RHAMM/TPX2 interactions are seen in several cell types and 
are important for proper microtubule and spindle assembly (100). Mutation of the three 
conserved leucine amino acids of the leucine zipper sequence in RHAMM to arginines 
disrupted TPX2 localization at the spindle poles and consequently proper activation of 
AURKA kinase activity(100). AURKA is an important regulator of the cell cycle and is 
essential for progression through mitosis (17). 
Collectively, previous data suggests that RHAMM mediates binding to microtubule 
structures, centrosomes, and the spindle assembly protein factor TPX2 through its 
carboxyl terminal leucine zipper sequence and these interactions play a role in the 
regulation of the mitotic spindle. Although these studies established a critical role for 
leucine zipper sequence, they did not assess a role for its dimerization function; the 
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consequences of mutating only one leucine residue, which would have compromised the 
dimerization motif of a leucine zipper, was not reported in these studies.  
With this in mind, this study first aimed to assess if RHAMM/microtubule interactions 
were mediated through a leucine zipper function and to ascertain if an intact leucine 
zipper was required for mitotic spindle integrity. The experimental approach that was 
taken was to disrupt the leucine zipper by site mutating single leucine residues. In doing 
so, we could assess if the leucine zipper function of dimerization was responsible for 
interactions with microtubules and the mitotic spindle.  
RHAMM interactions with microtubules [tubulin heterodimers], in vitro, were first 
assessed using synthesized RHAMM peptides containing the leucine zipper, both 
mutated and wildtype sequences. The consequences of a mutated leucine zipper on 
mitotic spindle assembly in culture were not directly assessed due to the difficulty in 
expressing GFP-tagged RHAMMΔ163. The effects of the leucine zipper mutations on 
RHAMM/mitotic spindle integrity were therefore examined indirectly using cell 
proliferation, cell cycle progression, and apoptosis as surrogate markers. Based on 
previous literature, it was predicted that RHAMM’s interactions with microtubules and 
the mitotic spindle would be disrupted and that alterations in key cellular events would be 
evident. 
Studies confirmed that RHAMM/tubulin interactions occur directly through RHAMM’s 
carboxyl terminus, but most importantly showed that this binding was not mediated by 
the leucine zipper motif. Under the conditions of this study, the ability of the L735R 
mutant to bind to tubulin was not compromised since it bound in similar amounts as 
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wildtype and since wildtype RHAMM peptide retained an ability to compete with L735R 
for binding to tubulin. RHAMM/tubulin interactions therefore do not require 
dimerization through a leucine zipper; however, the C-terminal RHAMM peptide used in 
this assay contains a site for microtubule binding. 
Furthermore, studies showed that disruption of the leucine zipper motif did not appear to 
have significant effects on mitotic spindle functions as assessed using the surrogate 
markers of cell proliferation, cell cycle progression and apoptosis.   
A minor inhibition of proliferation was seen in RHAMMΔ163 –transfected cells, however, 
the differences in proliferation between RHAMMΔ163-L735R, RHAMMΔ163-
L728A/L735R, and RHAMMΔ163 –expressing fibroblasts were very subtle in both 10T1/2 
and RHAMM-/- cell backgrounds. There were, however, slight differences observed in 
cell growth between L735R- and L728A/L735R-RHAMMΔ163 forms. These disparities, 
combined with our studies showing the apparent reversion of the third leucine in the 
leucine zipper region under selection pressure, predict a functional role of individual 
leucine residues as opposed to a leucine zipper function during cellular processes. The 
leucine zipper domain partially overlaps with the ERK docking site and the HA binding 
region and thus mutation of specific residues could impact on these functions, as 
RHAMM dependent ERK activation and RHAMM-HA interactions are known to 
mediate cell proliferation in numerous cell backgrounds (67, 109, 130, 131). 
In addition, RHAMMΔ163 did not alter 10T1/2 cell cycle progression compared to 
parental cells and disrupting the leucine zipper via expression of L735R or L728A/L735R 
did not modify the percentage of cells in each stage of the cell cycle. Given that 
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RHAMM is tightly regulated throughout the cell cycle and peaks at G2/M, if mitotic 
spindle assembly were compromised due to disrupted RHAMM/mitotic spindle 
interactions, a block in the mitotic phase of the cell cycle would be evident. Cells would 
be expected to arrest at G2/M, however this did not seem likely given our data. 
Furthermore, while we did not look at the cell cycle profile of synchronized cells, it is 
possible that these mutations impact the rate of cell cycle progression in a minor way, 
which has been shown to be RHAMM regulated (100). 
Data presented here further suggests that mutations in the leucine zipper motif do not 
impact apoptosis since levels of cell death did not differ between wildtype and mutant 
RHAMMΔ163-transfected 10T1/2 cells. Defects in mitotic spindle assembly or regulation 
have the potential to trigger the apoptotic machinery (84), but this did not appear likely in 
these studies. 
The conflicting data in the literature pertaining to RHAMM’s role during cell 
proliferation and cell cycle progression could partially be attributed to the levels of 
RHAMM protein expression and to the numerous RHAMM isoforms present in cell lines 
and in human cancers. The levels of spindle assembly protein factors must be finely 
tuned since abundance or inhibition can abrogate their function and regulation of the 
mitotic spindle (132). Certainly, RHAMM protein levels could contribute to the 
differences between the work presented here and previous studies showing that cells 
arrest at G2/M when RHAMM was ectopically overexpressed. For example, this study 
showed that 2.8-fold overexpression of RHAMM does not have an impact on the 
percentage of cells in different stages of the cell cycle, whereas other studies show that a 
5-fold overexpression of RHAMM arrests cells in G2/M (19).  
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Although the mechanism underlying the expression pattern or presence of the different 
RHAMM isoforms is not well established, studies predict that specific forms are 
generated during particular responses, localize to distinctive subcellular compartments 
and the effects they exert are often context-dependent and cell-type specific (69, 92, 94). 
Additionally, previous works often fail to indicate which RHAMM isoform is being 
studied/investigated, thus making it difficult to establish the specific functions of each 
RHAMM form and to elucidate the effects they have during particular cell processes.   
The discrepancy in cell proliferation seen in this study and previous work showing 
RHAMM either promotes or has no effect on cell proliferation may largely be due to 
differences in cell backgrounds. Studies showing no effect on cell proliferation when 
RHAMM expression is downregulated do, however, show that cell migration and 
invasion is inhibited in invasive breast cancer cell lines (133). 
The proliferation data on fibroblasts in this study, however, are consistent with previous 
literature suggesting that RHAMM overexpression does not promote cell growth and may 
even have an inhibitory effect on proliferation (117). This effect is quite surprising and 
unexpected given that overexpression of wildtype and mutant RHAMMΔ163 forms 
transformed 10T1/2 fibroblast cell lines and formed tumors when cells were injected in 
NOG immune compromised mice. While this was not the major focus of this study, these 
results suggest that the effect of RHAMMΔ163 isoform on 10T1/2 cell transformation is 
therefore unrelated mechanistically to cell proliferation. To our knowledge, this is the 
first study relating the tumorigenic properties of RHAMMΔ163 isoform in 10T1/2 MEFs 
to cell proliferation. 
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4.2 Functions of RHAMM in directed cell migration 
 
RHAMM also plays an essential role during cell migration. Given that RHAMM binds to 
centrosomes via the leucine zipper motif and that an intact centrosome is required for 
proper cell migration (19, 42), the second aim of this thesis was to determine if RHAMM 
mutated in the leucine zipper impacts directed cell motility. An underlying defect seen in 
RHAMM-/- fibroblasts is their inability to resurface scratch wounds due to their decreased 
rate of motility compared to wildtype or RHAMM rescued counterparts (64). The defects 
seen in migration are known to be due to aberrant activation of ERK1,2, but also were 
hypothesized to be a result of defects in centrosome function (64). Centrosomes are the 
main constituents of the MTOC and play an integral role during directed cell migration 
by polarizing the cell and positioning the MTOC in the direction of migration relative to 
the cell nucleus (124). RHAMM has been shown to not only regulate the position and 
function of centrosomes, but also cell polarization during migration (124).  
RHAMMΔ163-L735R-transfected RHAMM-/- fibroblasts showed a defect in cell migration 
that was characterized by fewer migrating cells into the scratch wounds and that was not 
attributed to a difference in cell proliferation. The alteration in migration could account 
for a reduced cell motility rate or aberrant directional cell migration. Tracking the 
motility of individual cells at the wound edge established that L735R- RHAMMΔ163 
transfected fibroblasts traveled shorter distances from the cell origin, with decreased, yet 
comparable motility rates as RHAMMΔ163 expressing cells. Whereas RHAMMΔ163 –
rescued cells moved into the scratch wounds, a portion of L735R- RHAMMΔ163 
expressing cells were directionally impaired as these cells traveled back into the 
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monolayer before moving into the scratch wound space. Interestingly, expression of 
L735R mutant resulted in the appearance of a small subset of cells with polycentrosomes 
during interphase. While a number of RHAMMΔ163 expressing cells also had more than 
one centrosome, the percentages were not different from RHAMM-/- parental fibroblasts.  
Previous studies had established a role for RHAMM in regulating centrosome volume in 
multiple myeloma plasma cells, but not centrosome number (81). Data from this study 
was based on experiments showing that centrosome number was not altered when 
RHAMM levels were overexpressed (81). This is consistent with work presented here in 
that overexpression of RHAMMΔ163 did not show an impact on centrosome number in 
RHAMM-/- cells, however, when mutating the centrosome binding region (i.e. leucine 
zipper) we saw an increase in the number of centrosomes per cell, suggesting a functional 
role of the leucine zipper in centrosome regulation, perhaps affecting centriolar 
replication. RHAMM is a known constituent of the pericentriolar material surrounding 
centrioles in the MTOC and regulation of PCM proteins is essential during centrosome 
duplication and separation; slight differences in the levels and function of PCM 
components have been shown to impact cell polarity (134, 135). Whether RHAMM plays 
a role in centrosome replication remains to be determined, but results here hypothesize 
that it is likely contributing and thus affecting cell directionality.  
Furthermore, while the majority of L735R- RHAMMΔ163 fibroblasts were front-
polarized, there was a trend for a greater number of cells that were rear-polarized (i.e. 
centrosome behind the nucleus), however, the percentages were not drastically different 
from RHAMMΔ163 or parental RHAMM-/- cells. This trend is consistent with RHAMM’s 
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role in regulating the position of centrosomes (84) and also suggests that this regulation 
partially depends on an intact leucine zipper motif. 
While the work presented here showed that expression of RHAMMΔ163-L735R in 
RHAMM-/- increases the number of polycentrosome cells, it did not establish whether 
this defect is associated to the directional defects seen in cell migration. Given that 
centrosomes help polarize and direct the cell during migration, we predict that the 
centrosome defect in L735R- RHAMMΔ163 cells may account for a defect in directional 
migration. Collectively, these results and hypothesis are supported by data showing that 
disrupted centrosomes in an epithelial cell line migrate at slower rates, though not 
significantly different from control cells, and in a disoriented direction away from the 
scratch wound, due to loss of polarity (42).  
It is well established that polycentrosomic cells contribute to defects in spindle pole 
assembly during mitosis (84, 135). However, the effects of polycentrosomes during 
interphase on non-mitotic functions are not well known. Recent work has identified that 
supernumery centrosomes impact directed cell migration of endothelial cells (135). 
Excess centrosomes, even one extra, resulted in altered directed cell migration with 
reduced distance traveled from cell origin into a scratch wound. Centrosome positioning 
was perturbed and centrosomes were more scattered; these defects could be partially 
rescued by ablating excess centrosomes and were shown to be independent of mitotic 
functions(135).  
This seemingly contradictory data suggests that polycentrome cells would result in multi-
pole mitotic spindles, though it doesn’t appear likely from our data. It is important to 
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note, however, that mitotic spindle and migration studies were investigated in 10T1/2 and 
RHAMM-/- fibroblasts, respectively. The distinctive cell backgrounds could contribute to 
the difference in results but warrants further investigation. 
An alternate interpretation for our results is that the defect in RHAMM’s regulation of 
centrosomes via its leucine zipper motif could have subtle affects on rate of cell cycle 
progression. Centrosomes begin replication during the S phase of the cell cycle, alongside 
DNA replication, and begin to separate during prophase of mitosis to initiate a bipolar 
mitotic spindle. A minor defect in the replication/separation of centrosomes could 
account for the presence of numerous cells with more than one centrosome. Future work 
will aim to investigate the contributing factors to migration defects and to elucidate 
RHAMM’s regulation of centrosome replication during mitosis and migration. 
Taken together, the data here suggests that the leucine zipper motif is critical for directed 
cell migration in fibroblasts. Despite mutations in the leucine zipper, expression of 
L735R- RHAMMΔ163 was able to rescue the rate of motility defect, though not 
directionality of RHAMM-/- fibroblasts. Further studies are needed to reveal a mechanism 
for RHAMM leucine zipper and centrosome interaction in directed cell migration and 
polarity. Previous work in our lab has established a role of RHAMM in random and 
directed motility that is dependent on RHAMM regulated ERK activation and subcellular 
localization (64). Future work will examine the impact of and the levels of ERK 
activation in mutant RHAMMΔ163-expressing fibroblasts.  
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4.3 Summary and future studies  
 
Our work suggests that the mechanism by which RHAMM regulates mitotic spindle 
integrity is very complex and involves multiple regulatory factors. To our knowledge, 
this is the first RHAMM study directly assessing a role for its leucine zipper dimerization 
motif on mitotic spindle functions and migration. While previous literature has no doubt 
established a vital role for leucine zipper sequence of RHAMM in maintaining mitotic 
spindle integrity, results here suggest that the leucine zipper isn’t functioning as a classic 
dimerization motif in mitotic spindle regulation. In previous studies, mutations of leucine 
residues to large arginine residues within this region may have altered the conformation 
of RHAMM protein and thus disrupted binding sites that may or may not overlap the 
leucine zipper region. Results presented here demonstrate that site mutating single 
leucine residues establish a role for the leucine zipper dimerization motif in directed cell 
migration. 
Recent work has identified a role of the leucines in the leucine zipper region of RHAMM 
in TPX2 interactions and for its proper localization and activation of AURKA (100). The 
consequence of TPX2/AURKA mislocalization has been shown to result in abnormal 
mitosis, characterized by shortened/compressed mitotic spindles giving rise to mitotic 
failure (100, 136). As proper positioning and alignment of the spindle poles relative to 
each other determine spindle length (137), it is likely that RHAMM’s role in maintaining 
spindle orientation is partially through its interactions with TPX2. Furthermore, TPX2 
has functions in mitotic spindle integrity that are independent of AURKA(11) and these 
functions may be in part mediated through RHAMM activity. Although it is assumed, 
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these studies have not established whether the leucine zipper is functioning as a 
dimerization motif in TPX2 interactions or if it is specific to leucine residues or 
overlapping binding sites. It is therefore difficult to predict whether our mutations, 
L735R or L728A/L735R, will contribute to TPX2 mislocalization and future studies will 
need to address this.  
Whether TPX2 is in fact regulating the major effect of RHAMM on mitotic spindles, has 
yet to be examined. Work in our lab has also shown that RHAMM’s effect on mitotic 
spindle assembly is indirectly through MEK1 activity since mutant active MEK1 has the 
ability to rescue mitotic defects seen in RHAMM-/- fibroblasts.  
Our studies also revealed an important role of the leucine zipper in directed cell motility, 
and thus future studies will need to address the role of RHAMM/TPX2 interactions on 
cell migration. The role of TPX2 in cell migration is an understudied area of research, but 
has been shown to regulate migration and invasion of colon cancer cell lines (138). A 
mechanism linking TPX2 and ERK, if any, with regards to mitotic spindle functions and 
migration will need to be elucidated. A full understanding of how RHAMM regulates 
these cell processes including mitosis and migration can provide insight on RHAMM’s 
role during cancer initiation and progression. 
 
Conclusions  
Results of this study show that RHAMM directly binds tubulin heterodimers in vitro via a 
carboxyl terminal sequence and further, that this interaction is not mediated by the 
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leucine zipper dimerization motif. Evidence presented in this study suggests that 
disrupting the leucine zipper by site mutating single leucine residues does not affect the 
binding of RHAMM to tubulin and importantly has no detectable effects on mitotic 
spindle integrity as assessed using the surrogate markers of cell cycle progression, cell 
proliferation, and apoptosis. However, ablating the leucine zipper function did aberrantly 
increase centrosome number in interphase cells and disrupted directed cell migration, 
which is a centrosome function. Our results, combined with previous work, suggest a 
model wherein extracellular RHAMM/ERK impacts rate of motility, while intracellular 
RHAMM interacts with centrosomes to control directed cell migration (Figure 4.1). 
 
Limitations 
Although this study provided data based on using a surrogate approach to assess whether 
RHAMM/mitotic spindle interactions were abolished, studies are needed to confirm 
direct effects in cell culture. Surrogate markers can provide insight albeit not definite 
results. Furthermore, while in vitro studies displayed that point mutations in the leucine 
zipper region do not disrupt binding to tubulin heterodimers, in vitro, we need to confirm 
it in cell culture. The lack of reliable RHAMM antibodies for immunofluorescence makes 
it challenging since expression of GFP tagged-RHAMM in cell lines is difficult.  
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Figure 4.1: Proposed model for RHAMM-regulated cell migration 
Cell surface RHAMM regulates ERK activation, which impacts rate of cell motility, 
while intracellular RHAMM forms interact with centrosome structures and affect polarity 
and directed cell migration 
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Appendices 
A) Experiment 1: Xenograft tumor formation summary 
 
B) Experiment 2: Xenograft tumor formation summary 
 
C) Experiment 3: Xenograft tumor formation summary 
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Appendix A Wet weights of wildtype and mutant 10T1/2-RHAMMΔ163 xenograft 
tumors  
10T1/2 RHAMMΔ163 expressing, wildtype or mutant, fibroblasts were subcutaneously 
injected in the flank of NSG immune compromised mice and tumor growth was 
monitored over 6 weeks. Mice that developed tumors were sacrificed and tumor wet 
weights were measured. Three separate experiments were carried out (A), B), and C)) 
with n=3 mice per cell line injected per experiment. Each bar under a given cell line 
represents the wet weight of a single tumor formed from an individual mouse from each 
experiment. Lack of bars or less than 3 bars under a given cell line identify that tumors 
did not form or that tumors did not form in all experimental mice, respectively. The 
differences in tumor weights between cell lines could not be compared as tumor-forming 
capabilities varied between experiments. Studies in our lab are currently underway to 
investigate the discrepancies in this data.     
 
 
